CDC Science Clips

Immunity and Immunization

1. Policy statement--Recommended childhood and adolescent immunization schedules--United States, 2010
   Pediatrics. 2010 Jan;125(1):195-6.


2. Recommended adult immunization schedule: United States, 2011
   Ann Intern Med. 2011 Feb 1;154(3):168-73.


3. Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak
   Abedi GR, Mutuc JD, Lawler J, Leroy ZC, Hudson JM, Blog DS, Schulte CR, Rausch-Phung E, Ogbuanu IU, Gallagher K, Kutty PK.
   Vaccine. 2012 Oct 3.


4. Seasonal influenza vaccine coverage among pregnant women: Pregnancy Risk Assessment Monitoring System
   Ahluwalia IB, Singleton JA, Jamieson DJ, Rasmussen SA, Harrison L.
   J Womens Health (Larchmt). 2011 Mar 25.


5. Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC)
   Ahmed F, Temte JL, Campos-Outcalt D, Schunemann HJ.
   Vaccine. 2011 Aug 10.


6. Update: Vaccines for women, adolescence through adulthood
   Akinsanya-Beysolow I, Wolfe CS.
   J Womens Health (Larchmt). 2009 Aug;18(8):1101-8.


7. The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain
   Albarino CG, Bird BH, Chakrabarti AK, Dodd KA, Flint M, Bergeron E, White DM, Nichol ST.
   J Virol. 2011 Jul 27.


8. Timing of adolescent meningococcal conjugate vaccination: attitudes and practices of pediatricians and family medicine physicians
   Allison MA, Cohn AC, Stokley S, Crane LA, O'Leary ST, Hurley LP, Babbel CI, Dong F, Gahm C, Temte JL, Kempe A.
   Am J Prev Med. 2011 Dec;41(6):581-7.


9. The impact of missed opportunities on seasonal influenza vaccination coverage for healthy young children
   Allred NJ, Poehling KA, Szilagyi PG, Zhang F, Edwards KM, Staat MA, Donauer S, Prill MM, Fairbrother G.
   J Public Health Manag Pract. 2011 Nov;17(6):560-564.


10. Improving influenza vaccine virus selection: Report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010
    Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, Siqueira M, Tashiro M, Waddell AL, Wairagkar N, Wood J, Zambon M, Zhang W.
    Influenza Other Respi Viruses. 2011 Aug 8.


11. Building on success--potential to improve coverage of multiple health interventions through integrated delivery with routine childhood vaccination
    Anand A, Luman ET, O'Connor PM.
    J Infect Dis. 2012 Mar;205 Suppl 1:S28-39.


12. Nasopharyngeal carriage of Streptococcus pneumoniae in very low-birth-weight infants after administration of heptavalent pneumococcal conjugate vaccine
    Ang JY, Lua JL, Asmar BI, Shankaran S, Heyne RJ, Schelonka RL, Das A, Li L, Jackson DM, Higgins RD, D'Angio CT.
    Arch Pediatr Adolesc Med. 2010 Dec;164(12):1173-5.


13. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children
    Anh DD, Van Trang N, Thiem VD, Anh NT, Mao ND, Wang Y, Jiang B, Hien ND, Luan LT.
    Vaccine. 2012 27 Apr;30 Suppl 1:A114-A121.


14. Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey
    Anhang Price R, Tiro JA, Saraiya M, Meissner H, Breen N.
    Cancer. 2011 15 Dec;117(24):5560-5568.


15. Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement
    Ansaldi F, Durando P, Icardi G.
    Expert Opin Biol Ther. 2011 Mar;11(3):415-27.


16. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials
    Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, Danquah I, Dodoo A, Kobbe R, Lell B, May J, Premji Z, Sanz S, Sevene E, Soulaymani-Becheikh R, Winstanley P, Adjei S, Anemana S, Chandramohan D, Issifou S, Mockenhaupt F, Owusu-Agyei S, Greenwood B, Grobusch MP, Kremsner PG, Macete E, Mshinda H, Newman RD, Slutsker L, Tanner M, Alonso P, Menendez C.
    Lancet. 2009 Oct 31;374(9700):1533-42.


17. Immunogenicity of the pentavalent rotavirus vaccine in African infants
    Armah GE, Breiman RF, Tapia MD, Dallas MJ, Neuzil KM, Binka FN, Sow SO, Ojwando J, Ciarlet M, Steele AD.
    Vaccine. 2012 Apr 27;30 Suppl 1:A86-93.


18. How much could rotavirus vaccines reduce diarrhea-associated mortality in northern Ghana? A model to assess impact
    Arvay ML, Curns AT, Terp S, Armah G, Wontuo P, Parashar UD, Binka F, Glass RI, Widdowson MA.
    J Infect Dis. 2009 Nov 1;200 Suppl 1:S85-91.


19. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030
    Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD.
    Vaccine. 2012 Apr 27;30 Suppl 1:A7-A14.


20. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030
    Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD.
    Vaccine. 2012 Apr 27;30 Suppl 1:A7-14.


21. Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States
    Atkins CY, Patel A, Taylor TH, Biggerstaff M, Merlin TL, Dulin SM, Erickson BA, Borse RH, Hunkler R, Meltzer MI.
    Emerg Infect Dis. 2011 Sep;17(9):1591-8.


22. The role of the GAVI Alliance in improving childhood hepatitis B vaccination in China: successes, lessons learned, and future global challenges
    Averhoff F, Kolwaite A, Ward JW.
    Vaccine. 2013 Apr 24.


23. The Vaccine Safety Datalink: A model for monitoring immunization safety
    Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, Naleway A, Klein NP, Baxter R, Belongia E, Glanz J, Hambidge SJ, Jacobsen SJ, Jackson L, Nordin J, Weintraub E.
    Pediatrics. 2011 Apr 18.


24. Recommended adult immunization schedule: United States, 2010
    Baker CJ, Pickering LK, Chilton ., Cieslak P, Ehresmann KR, Englund J, Friedman C, Judson FN, Keitel WA, Lett SM, Plain J, Marcy MS, Meissner CH, Neuzil K, Sawyer MH, Sumaya CV, Temte J, Advisory Committee on Immunization Practices.
    Ann Intern Med. 2010 Jan 5;152(1):36-9.


25. Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions
    Baldwin SL, Fox CB, Pallansch MA, Coler RN, Reed SG, Friede M.
    Vaccine. 2011 Jan 17;29(4):644-9.


26. Knowledge, attitude, and practices about the seasonal influenza vaccination among healthcare workers in Srinagar, India
    Bali NK, Ashraf M, Ahmad F, Khan UH, Widdowson MA, Lal RB, Koul PA.
    Influenza Other Respi Viruses. 2012 Aug 2.


27. The new H1N1 and HPV vaccines and old fears
    Balofsky A, Agmon-Levin N, Shoenfeld Y.
    Curr Opin Rheumatol. 2010 Jul;22(4):431-6.


28. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs
    Banyai K, Laszlo B, Duque J, Steele AD, Nelson EA, Gentsch JR, Parashar UD.
    Vaccine. 2012 Apr 27;30 Suppl 1:A122-30.


29. Broad neutralization of wild-type dengue virus isolates following immunization in monkeys with a tetravalent dengue vaccine based on chimeric yellow fever 17D/dengue viruses
    Barban V, Munoz-Jordan JL, Santiago GA, Mantel N, Girerd Y, Gulia S, Claude JB, Lang J.
    Virology. 2012 Aug 1;429(2):91-8.


30. Do vaccination strategies implemented by nursing homes narrow the racial gap in receipt of influenza vaccination in the United States?
    Bardenheier B, Shefer A, Ahmed F, Remsburg R, Rowland Hogue CJ, Gravenstein S.
    J Am Geriatr Soc. 2011 Mar 25.


31. Influenza immunization coverage among residents of long-term care facilities certified by CMS, 2005-2006: the newest MDS quality indicator
    Bardenheier BH, Wortley P, Ahmed F, Hales C, Shefer A.
    J Am Med Dir Assoc. 2010 Jan;11(1):59-69.


32. Thimerosal exposure in early life and neuropsychological outcomes 7-10 years later
    Barile JP, Kuperminc GP, Weintraub ES, Mink JW, Thompson WW.
    J Pediatr Psychol. 2011 Jul 23.


33. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37
    Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, Davidson DJ, Donis RO.
    PLoS One. 2011 ;6(10):e25333.


34. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)
    Bar-On ES, Goldberg E, Fraser A, Vidal L, Hellmann S, Leibovici L.
    Cochrane Database Syst Rev. 2009 (3):CD005530.


35. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season
    Barr IG, McCauley J, Cox N, Daniels R, Engelhardt OG, Fukuda K, Grohmann G, Hay A, Kelso A, Klimov A, Odagiri T, Smith D, Russell C, Tashiro M, Webby R, Wood J, Ye Z, Zhang W.
    Vaccine. 2010 Feb 3;28(5):1156-67.


36. The potential economic value of a human norovirus vaccine for the United States
    Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY.
    Vaccine. 2012 Nov 19;30(49):7097-104.


37. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season
    Bateman AC, Kieke BA, Irving SA, Meece JK, Shay DK, Belongia EA.
    J Infect Dis. 2013 Apr 15;207(8):1262-9.


38. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies
    Batteiger BE, Xu F, Johnson RE, Rekart ML.
    J Infect Dis. 2010 Jun 15;201 Suppl 2:S178-89.


39. Factors associated with receipt of 2009 pandemic influenza A (H1N1) monovalent and seasonal influenza vaccination among school-aged children: Maricopa County, Arizona, 2009-2010 influenza season
    Baty SA, Ayala A, Odish M, Cadwell BL, Schumacher M, Sunenshine RH.
    J Public Health Manag Pract. 2013 Apr 1.


40. Recurrent Guillain-Barre syndrome following vaccination
    Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP.
    Clin Infect Dis. 2012 Mar;54(6):800-804.


41. Varicella immunity in vaccinated healthcare workers
    Behrman A, Lopez AS, Chaves SS, Watson BM, Schmid DS.
    J Clin Virol. 2013 Jun;57(2):109-14.


42. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine
    Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, Yin R, Lieu TA, Weintraub E, Yih WK, Li R, Baggs J, The Vaccine Safety Datalink Investigation Group.
    Pediatr Infect Dis J. 2009 Nov 10.


43. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results
    Belongia EA, Kieke BA, Donahue JG, Coleman LA, Irving SA, Meece JK, Vandermause M, Lindstrom S, Gargiullo P, Shay DK.
    Vaccine. 2011 Sep 2;29(38):6558-63.


44. Monitoring of rotavirus vaccination in Morocco: establishing the baseline burden of rotavirus disease
    Benhafid M, Rguig A, Trivedi T, Elqazoui M, Teleb N, Mouane N, Maltouf AF, Parashar U, Patel M, Aouad RE.
    Vaccine. 2012 Oct 12;30(46):6515-20.


45. Does vitamin A supplementation interact with routine vaccinations? An analysis of the Ghana vitamin A supplementation trial
    Benn CS, Aaby P, Nielsen J, Binka FN, Ross DA.
    Am J Clin Nutr. 2009 Sep;90(3):629-39.


46. Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the Marshall Islands and the Federated States of Micronesia
    Bialek SR, Helgenberger L, Fischer GE, Bower WA, Konelios M, Chaine JP, Armstrong G, Williams IT, Bell BP.
    Pediatr Infect Dis J. 2009 Oct 16.


47. Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni
    Black CL, Muok EM, Mwinzi PN, Carter JM, Karanja DM, Secor WE, Colley DG.
    J Infect Dis. 2010 Jun 18.


48. Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: an integrated analysis
    Black S, Della Cioppa G, Malfroot A, Nacci P, Nicolay U, Pellegrini M, Sokal E, et al.
    Vaccine. 2010 Oct 21;28(45):7331-6.


49. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
    Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, Vannice K, Izurieta HS, Akhtar A, Gold M, Oselka G, Zuber P, Pfeifer D, Vellozzi C.
    Lancet. 2009 Oct 30;374(9707):2115-22.


50. Discussing vaccination with concerned patients: an evidence-based resource for healthcare providers
    Blendell RL, Fehr JL.
    J Perinat Neonatal Nurs. 2012 Jul-Sep;26(3):230-41.


51. Policy statement--Recommended childhood and adolescent immunization schedules--United States, 2010
    Bocchini J, Bradley J, Brady M, Bernstein H, Byington C, Fisher M, Glode M, Jackson M, Keyserling H, Kimberlin D, Orenstein W, Schutze G, Willoughby R, Bell B, Bortolussi R, Clover R, Fischer M, Gorman R, Lee L, Pratt R, Read J, Gellin B, Starke J, Swanson J, Meissner H, Rubin L, Pickering L, Baker C, Long S, Frantz J, Committee on Infectious Diseases.
    Pediatrics. 2010 Jan;125(1):195-6.


52. A group-randomized evaluation of a quality improvement intervention to improve influenza vaccination rates in dialysis centers
    Bond TC, Patel PR, Krisher J, Sauls L, Deane J, Strott K, McClellan W.
    Am J Kidney Dis. 2011 Feb;57(2):283-90.


53. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series
    Boom JA, Sahni LC, Payne DC, Gautam R, Lyde F, Mijatovic-Rustempasic S, Bowen MD, Tate JE, Rench MA, Gentsch JR, Parashar UD, Baker CJ.
    J Infect Dis. 2012 Oct;206(8):1275-9.


54. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States
    Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, Patel MM, Baker CJ, Parashar UD.
    Pediatrics. 2010 Feb;125(2):e199-207.


55. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban US pediatric hospital
    Boom JA, Tate JE, Sahni LC, Rench MA, Quaye O, Mijatovic-Rustempasic S, Patel MM, Baker CJ, Parashar UD.
    Pediatr Infect Dis J. 2010 Jul 14.


56. Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010
    Borse RH, Shrestha SS, Fiore AE, Atkins CY, Singleton JA, Furlow C, Meltzer MI.
    Emerg Infect Dis. 2013 ;19(3):439-448.


57. Unvaccinated children in years of increasing coverage: how many and who are they? Evidence from 96 low- and middle-income countries
    Bosch-Capblanch X, Banerjee K, Burton A.
    Trop Med Int Health. 2012 Jun;17(6):697-710.


58. PAMPer and tRIGer: ligand-induced activation of RIG-I
    Bowzard JB, Davis WG, Jeisy-Scott V, Ranjan P, Gangappa S, Fujita T, Sambhara S.
    Trends Biochem Sci. 2011 Apr 14.


59. Vaccination with Haemophilus influenzae type b conjugate vaccine reduces bacterial meningitis in Morocco
    Braikat M, Barkia A, Mdaghri NE, Rainey JJ, Cohen AL, Teleb N.
    Vaccine. 2012 Mar 28;30(15):2594-9.


60. A qualitative analysis of vaccine safety perceptions and concerns among caretakers in Uganda
    Braka F, Asiimwe D, Soud F, Lewis RF, Makumbi I, Gust D.
    Matern Child Health J. 2012 Jul;16(5):1045-52.


61. Food allergy among children in the United States
    Branum AM, Lukacs SL.
    Pediatrics. 2009 Nov 16.


62. What is health equity: and how does a life-course approach take us further toward it?
    Braveman P.
    Matern Child Health J. 2013 Feb 10.


63. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children
    Breiman RF, Brooks WA, Goswami D, Lagos R, Borja-Tabora C, Lanata CF, Londono JA, Lum LC, Rappaport R, Razmpour A, Walker RE, Gruber WC, Forrest BD.
    Vaccine. 2009 Sep 4;27(40):5472-9.


64. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine
    Breiman RF, Zaman K, Armah G, Sow SO, Anh DD, Victor JC, Hille D, Ciarlet M, Neuzil KM.
    Vaccine. 2012 Apr 27;30 Suppl 1:A24-9.


65. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area
    Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, Smith JS.
    Sex Transm Dis. 2011 Mar;38(3):197-204.


66. Inside this year's flu vaccine
    Bridges C.
    Consum Rep Health. 2010 ;22(11):6-6.[Request a copy via DocExpress]
    


67. Haemophilus influenzae type B disease and vaccine booster dose deferral, United States, 1998-2009
    Briere EC, Jackson M, Shah SG, Cohn AC, Anderson RD, Macneil JR, Coronado FM, Mayer LW, Clark TA, Messonnier NE.
    Pediatrics. 2012 Aug 6.


68. Impact of integration of hygiene kit distribution with routine immunizations on infant vaccine coverage and water treatment and handwashing practices of Kenyan mothers
    Briere EC, Ryman TK, Cartwright E, Russo ET, Wannemuehler KA, Nygren BL, Kola S, Sadumah I, Ochieng C, Watkins ML, Quick R.
    J Infect Dis. 2012 Mar;205 Suppl 1:S56-64.


69. Bridging the gap between data and public health needs. In the heat of a signal: responding to a vaccine safety signal for febrile seizures after 2010-11 influenza vaccine in young children, United States
    Broder KR, Martin DB, Vellozzi C.
    Vaccine. 2012 Mar 2;30(11):2032-4.


70. In the heat of a signal: responding to a vaccine safety signal for febrile seizures after 2010-11 influenza vaccine in young children, United States
    Broder KR, Martin DB, Vellozzi C.
    Vaccine. 2012 Mar 2;30(11):2032-4.


71. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
    Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM.
    Lancet. 2011 Jun 18;377(9783):2085-92.


72. Validity of parental report of influenza vaccination in young children seeking medical care
    Brown C, Clayton-Boswell H, Chaves SS, Prill MM, Iwane MK, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA, Fairbrother G, Hall CB, Zhu Y, Bridges CB.
    Vaccine. 2011 Nov 28;29(51):9488-9492.


73. Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus
    Brown DS, Johnson FR, Poulos C, Messonnier ML.
    Vaccine. 2010 Feb 17;28(7):1702-8.


74. Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review
    Brown KF, Kroll JS, Hudson MJ, Ramsay M, Green J, Long SJ, Vincent CA, et al.
    Vaccine. 2010 Jun 11;28(26):4235-48.


75. Middle school vaccination requirements and adolescent vaccination coverage
    Bugenske E, Stokley S, Kennedy A, Dorell C.
    Pediatrics. 2012 May 7.


76. Middle school vaccination requirements and adolescent vaccination coverage
    Bugenske E, Stokley S, Kennedy A, Dorell C.
    Pediatrics. 2012 May 7.


77. Associated factors for recommending HBV vaccination to children among Georgian health care workers
    Butsashvili M, Kamkamidze G, Topuridze M, Morse D, Triner W, Dehovitz J, Nelson K, McNutt LA.
    BMC Infect Dis. 2012 ;12:362.


78. Long-term immunogenicity of inactivated hepatitis A vaccine: follow-up at 15 years
    Byrd KK, Bruden DL, Bruce MG, Bulkow LR, Zanis CL, Snowball MM, Homan CE, Hennessy TW, Williams JL, Dunaway E, Chaves SS, McMahon BJ.
    J Pediatr Infect Dis. 2010 ;5(4):321-326.


79. Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination
    Byrd KK, Lu PJ, Murphy TV.
    Vaccine. 2012 Mar 31.


80. Predictors of hepatitis A vaccination among young children in the United States
    Byrd KK, Santibanez TA, Chaves SS.
    Vaccine. 2011 Feb 22.


81. Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income countries? An update
    Cairns KL, Perry RT, Ryman TK, Nandy RK, Grais RF.
    J Infect Dis. 2011 Jul;204 Suppl 1:S35-46.


82. Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: a randomized study in US adults
    Campbell JD, Chambers CV, Brady RC, Caldwell MC, Bennett NL, Fourneau MA, Jain VK, Innis BL.
    Hum Vaccin. 2011 Jan 1;7(1).


83. Improving immunogenicity and effectiveness of influenza vaccine in older adults
    Cao W, Kim JH, Chirkova T, Reber AJ, Biber R, Shay DK, Sambhara S.
    Expert Rev Vaccines. 2011 Nov;10(11):1529-37.


84. Towards validated assays for key immunological outcomes in malaria vaccine development
    Cavanagh DR, Dubois PM, Holtel A, Kisser A, Leroy O, Locke E, Moorthy VS, Remarque EJ, Shi YP.
    Vaccine. 2011 Apr 12;29(17):3093-5.


85. The need for innovative strategies to improve immunisation services in rural Zimbabwe
    Chadambuka A, Chimusoro A, Apollo T, Tshimanga M, Namusisi O, Luman ET.
    Disasters. 2011 May 31.


86. Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine
    Chang HG, Smith PF, Tserenpuntsag B, Markey K, Parashar U, Morse DL.
    Vaccine. 2010 Jan 8;28(3):754-8.


87. U.S. postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007
    Chang S, O'Connor PM, Slade BA, Woo EJ.
    Vaccine. 2013 Feb 27;31(10):1447-52.


88. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission
    Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, Kourtis AP, Martinson F, Tegha G, Knight RJ, Ahmed YI, Kamwendo DD, Hoffman IF, Ellington SR, Kacheche Z, Soko A, Wiener JB, Fiscus SA, Kazembe P, Mofolo IA, Chigwenembe M, Sichali DS, van der Horst CM.
    N Engl J Med. 2010 Jun 17;362(24):2271-81.


89. Current controversies in the USA regarding vaccine safety
    Chatterjee A, O'Keefe C.
    Expert Rev Vaccines. 2010 May;9(5):497-502.


90. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection
    Chaves SS, Daniels D, Cooper BW, Malo-Schlegel S, Macarthur S, Robbins KC, Kobetitsch JF, McDaniel A, D'Avella JF, Alter MJ.
    Vaccine. 2011 Oct 29.


91. Persistence of long-term immunity to hepatitis B among adolescents immunized at birth
    Chaves SS, Fischer G, Groeger J, Patel PR, Thompson ND, Teshale EH, Stevenson K, Yano VM, Armstrong GL, Samandari T, Kamili S, Drobeniuc J, Hu DJ.
    Vaccine. 2012 Jan 10.


92. Improved anamnestic response among adolescents boosted with a higher dose of the hepatitis B vaccine
    Chaves SS, Groeger J, Helgenberger L, Auerbach SB, Bialek S, Hu DJ, Drobeniuc J.
    Vaccine. 2010 Feb 11.


93. Varicella in infants after implementation of the US varicella vaccination program
    Chaves SS, Lopez AS, Watson TL, Civen R, Watson B, Mascola L, Seward JF.
    Pediatrics. 2011 Nov 28.


94. The yin and yang of paracetamol and paediatric immunisations
    Chen RT, Clark TA, Halperin SA.
    Lancet. 2009 Oct 17;374(9698):1305-6.


95. Preparing for the availability of a partially effective HIV vaccine: lessons from other licensed vaccines
    Chen RT, Hu DJ, Dunne E, Shaw M, Mullins J, Rerks-Ngarm S.
    Vaccine. 2011 Jul 8.


96. The cost-effectiveness of male HPV vaccination in the United States
    Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE.
    Vaccine. 2011 Aug 1.


97. Modeling the impact of quadrivalent HPV vaccination on the incidence of Pap test abnormalities in the United States
    Chesson HW, Flagg EW, Koutsky L, Hsu K, Unger ER, Shlay JC, Kerndt P, Ghanem KG, Zenilman JM, Hagensee M, Weinstock H, Datta SD.
    Vaccine. 2013 May 9.


98. Nasopharyngeal carriage of streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings
    Cheung YB, Zaman SM, Nsekpong ED, Van Beneden CA, Adegbola RA, Greenwood B, Cutts FT.
    Pediatr Infect Dis J. 2009 Nov;28(11):990-995.


99. MCV vaccination in the presence of vaccine-associated Guillain-Barre Syndrome risk: a decision analysis approach
    Cho BH, Clark TA, Messonnier NE, Ortega-Sanchez IR, Weintraub E, Messonnier ML.
    Vaccine. 2010 Jan 8;28(3):817-22.


100. Guillain-Barre syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition
     Choe YJ, Cho H, Bae GR, Lee JK.
     Vaccine. 2011 Jan 19.


101. Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys
     Chor JS, Ngai KL, Goggins WB, Wong MC, Wong SY, Lee N, Leung TF, Rainer TH, Griffiths S, Chan PK.
     BMJ. 2009 ;339:b3391.


102. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination
     Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, Seward JF.
     Pediatr Infect Dis J. 2009 Nov;28(11):954-9.


103. Perspectives of allergists/immunologists on the 2009-2010 H1N1 vaccination effort
     Clark SJ, Cowan AE, Wortley PM.
     J Asthma. 2012 Mar;49(2):184-9.


104. Perspectives of pulmonologists on the 2009-2010 H1N1 vaccination effort
     Clark SJ, Cowan AE, Wortley PM.
     Pulm Med. 2012 ;2012:306207.


105. Involvement of endocrinologists in the 2009 to 2010 H1N1 vaccination effort
     Clark SJ, Cowan AE, Wortley PM.
     Endocr Pract. 2012 Jul 1;18(4):464-71.


106. Pertussis control: time for something new?
     Clark TA, Messonnier NE, Hadler SC.
     Trends Microbiol. 2012 Apr 9.


107. Parents' acceptance of adolescent immunizations outside of the traditional medical home
     Clevenger LM, Pyrzanowski J, Curtis CR, Bull S, Crane LA, Barrow JC, Kempe A, Daley MF.
     J Adolesc Health. 2011 Aug;49(2):133-40.


108. An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States
     Cohen AL, Taylor T, Farley MM, Schaffner W, Lesher LJ, Gershman KA, Bennett NM, Reingold A, Thomas A, Baumbach J, Harrison LH, Petit S, Beall B, Zell E, Moore M.
     PLoS One. 2012 ;7(8):e41785.


109. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease
     Cohn AC, Macneil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, Pondo T, Arnold KE, Baumbach J, Bennett N, Craig AS, Farley M, Gershman K, Petit S, Lynfield R, Reingold A, Schaffner W, Shutt KA, Zell ER, Mayer LW, Clark T, Stephens D, Messonnier NE.
     Clin Infect Dis. 2009 Dec 14.


110. Inching toward a serogroup B meningococcal vaccine for infants
     Cohn AC, Messonnier NE.
     JAMA. 2012 Feb 8;307(6):614-5.


111. Direct costs of a single case of refugee-imported measles in Kentucky
     Coleman MS, Garbat-Welch L, Burke H, Weinberg M, Humbaugh K, Tindall A, Cambron J.
     Vaccine. 2011 Nov 11.


112. Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients
     Cooper CJ, Metch B, Dragavon J, Coombs RW, Baden LR.
     JAMA. 2010 Jul 21;304(3):275-83.


113. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil
     Correia JB, Patel MM, Nakagomi O, Montenegro FM, Germano EM, Correia NB, Cuevas LE, Parashar UD, Cunliffe NA, Nakagomi T.
     J Infect Dis. 2010 Feb 1;201(3):363-9.


114. Rotavirus vaccine and health care utilization for diarrhea in U.S. children
     Cortes JE, Curns AT, Tate JE, Cortese MM, Patel MM, Zhou F, Parashar UD.
     N Engl J Med. 2011 Sep 22;365(12):1108-17.


115. Underestimates of intussusception rates among US infants based on inpatient discharge data: implications for monitoring the safety of rotavirus vaccines
     Cortese MM, Staat MA, Weinberg GA, Edwards K, Rice MA, Szilagyi PG, Hall CB, Payne DC, Parashar UD.
     J Infect Dis. 2009 Nov 1;200 Suppl 1:S264-70.


116. Contribution of dendritic cells to measles virus induced immunosuppression
     Coughlin MM, Bellini WJ, Rota PA.
     Rev Med Virol. 2012 Dec 20.


117. Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005
     Cui F, Li L, Hadler SC, Wang F, Zheng H, Chen Y, Gong X, Hutin YJ, Cairns KL, Liang X, Yang W.
     Vaccine. 2010 Aug 23;28(37):5973-8.


118. Projected impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015
     Curns AT, Coffin F, Glasser JW, Glass RI, Parashar UD.
     J Infect Dis. 2009 Nov 1;200 Suppl 1:S49-56.


119. Remarkable postvaccination spatiotemporal changes in United States rotavirus activity
     Curns AT, Panozzo CA, Tate JE, Payne DC, Patel MM, Cortese MM, Parashar UD.
     Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S54-5.


120. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states
     Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD.
     J Infect Dis. 2010 Apr 19.


121. Human papillomavirus vaccination practices: survey of US physicians 18 months after licensure
     Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, Babbel C, Gottlieb SL, Liddon N, Stokley S, Dickinson LM, Kempe A.
     Pediatrics. 2010 Aug 2.


122. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure
     Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, Babbel C, Gottlieb SL, Liddon N, Stokley S, Dickinson LM, Kempe A.
     Pediatrics. 2010 Sep;126(3):425-33.


123. Adolescent immunization delivery in school-based health centers: a national survey
     Daley MF, Curtis CR, Pyrzanowski J, Barrow J, Benton K, Abrams L, Federico S, Juszczak L, Melinkovich P, Crane LA, Kempe A.
     J Adolesc Health. 2009 Nov;45(5):445-52.


124. Evaluation of smallpox vaccines using variola neutralization
     Damon IK, Davidson WB, Hughes CM, Olson VA, Smith SK, Holman RC, Frey SE, Newman F, Belshe RB, Yan L, Karem K.
     J Gen Virol. 2009 Aug;90(Pt 8):1962-6.


125. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011
     Date KA, Vicari A, Hyde TB, Mintz E, Danovaro-Holliday MC, Henry A, Tappero JW, Roels TH, Abrams J, Burkholder BT, Ruiz-Matus C, Andrus J, Dietz V.
     Emerg Infect Dis. 2011 ;17(11):2105-2112.


126. The expanding vaccine development pipeline, 1995-2008
     Davis MM, Butchart AT, Coleman MS, Singer DC, Wheeler JR, Pok A, Freed GL.
     Vaccine. 2009 Nov 20.


127. Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipeline
     Davis MM, Butchart AT, Wheeler JR, Coleman MS, Singer DC, Freed GL.
     Vaccine. 2011 Oct 12.


128. Carriage of Haemophilus influenzae among Brazilian children attending day care centers in the era of widespread Hib vaccination
     de Carvalho CX, Kipnis A, Thorn L, de Andrade JG, Pimenta F, Brandileone MC, Zanella RC, Flannery B, Sgambatti S, Andrade AL.
     Vaccine. 2011 Feb 4;29(7):1438-42.


129. Seasonal influenza vaccine provides priming for A/H1N1 immunization
     Del Giudice G, Stittelaar K, van Amerongen G, Simon J, Osterhaus A, Stohr K, Rappuoli R.
     Sci Transl Med. 2009 Dec 23;1(12):12re1.


130. Alternative vaccination schedule preferences among parents of young children
     Dempsey AF, Schaffer S, Singer D, Butchart A, Davis M, Freed GL.
     Pediatrics. 2011 Oct 3.


131. Potential intussusception risk versus benefits of rotavirus vaccination in the United States
     Desai R, Cortese MM, Meltzer MI, Shankar M, Tate JE, Yen C, Patel MM, Parashar UD.
     Pediatr Infect Dis J. 2012 Aug 27.


132. Impact of rotavirus vaccine on diarrhea-associated disease burden among American Indian and Alaska Native children
     Desai R, Haberling D, Holman RC, Singleton RJ, Cheek JE, Groom AV, Steiner CA, Parashar UD, Esposito DH.
     Pediatrics. 2012 Apr;129(4):e907-13.


133. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America
     Desai R, Parashar UD, Lopman B, Helena de Oliveira L, Clark AD, Sanderson CF, Tate JE, Matus CR, Andrus JK, Patel MM.
     Clin Infect Dis. 2012 Mar 19.


134. Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism
     DeStefano F, Price C, Weintraub E.
     J Pediatr. 2013 .


135. Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism
     DeStefano F, Price CS, Weintraub ES.
     J Pediatr. 2013 .


136. H1N1 vaccine safety monitoring: beyond background rates
     Destefano F, Tokars J.
     Lancet. 2009 Oct 30.


137. Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccines
     DeStefano F, Vellozzi C, Schonberger LB, Chen RT.
     BMJ. 2011 ;343:d4159.


138. Successful seroresponses to measles and rubella following aerosolized Triviraten vaccine, but poor response to aerosolized mumps (Rubini) component: comparisons with injected MMR
     Diaz-Ortega JL, Bennett JV, Castaneda D, Vieyra JR, Valdespino-Gomez JL, de Castro JF.
     Vaccine. 2010 Jan 8;28(3):692-8.


139. Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic (H1N1) influenza, 2009
     Dimitrov N, Goll S, Meyers LA, Pourbohloul B, Hupert N.
     PLoS Curr Influenza. 2009 :RRN1127.


140. Influenza vaccination coverage among pregnant women--National 2009 H1N1 Flu Survey (NHFS)
     Ding H, Santibanez TA, Jamieson DJ, Weinbaum CM, Euler GL, Grohskopf LA, Lu PJ, Singleton JA.
     Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S96-106.


141. Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience
     Djingarey MH, Barry R, Bonkoungou M, Tiendrebeogo S, Sebgo R, Kandolo D, Lingani C, Preziosi MP, Zuber PL, Perea W, Hugonnet S, Dellepiane de Rey Tolve N, Tevi-Benissan C, Clark TA, Mayer LW, Novak R, Messonier NE, Berlier M, Toboe D, Nshimirimana D, Mihigo R, Aguado T, Diomande F, Kristiansen PA, Caugant DA, Laforce FM.
     Vaccine. 2012 Apr 30;30 Suppl 2:B40-5.


142. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis
     do Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, Lopman B, Flannery B, de Oliveira LH, Hage Carmo E, Patel M.
     PLoS Med. 2011 Apr;8(4):e1001024.


143. Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge
     Dodd KA, Bird BH, Metcalfe MG, Nichol ST, Albarino CG.
     J Virol. 2012 Apr;86(8):4204-12.


144. Structures, roles, and procedures of state advisory committees on immunization
     Dolen V, Talkington K, Bhatt A, Rodewald L.
     J Public Health Manag Pract. 2013 Feb 27.


145. Feasibility of initiating and sustaining registry-based immunization recall in private practices
     Dombkowski KJ, Cowan AE, Harrington LB, Allred NJ, Hudson E, Clark SJ.
     Acad Pediatr. 2012 Feb 7.


146. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production
     Dong J, Matsuoka Y, Maines TR, Swayne DE, O'Neill E, Davis CT, Van-Hoven N, Balish A, Yu HJ, Katz JM, Klimov A, Cox N, Li DX, Wang Y, Guo YJ, Yang WZ, Donis RO, Shu YL.
     Influenza Other Respi Viruses. 2009 Nov;3(6):287-295.


147. Prospecting the influenza hemagglutinin to develop universal vaccines
     Donis RO, Cox NJ.
     Clin Infect Dis. 2011 Apr;52(8):1010-2.


148. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
     Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK.
     Lancet Infect Dis. 2010 Nov 8.


149. Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey-Teen, 2010
     Dorell C, Yankey D, Kennedy A, Stokley S.
     Clin Pediatr (Phila). 2013 Feb;52(2):162-70.


150. Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, National Immunization Survey--Teen, 2009
     Dorell C, Yankey D, Strasser S.
     Clin Pediatr (Phila). 2011 Aug 19.


151. Validity of parent-reported vaccination status for adolescents aged 13-17 years: National Immunization Survey-Teen, 2008
     Dorell CG, Jain N, Yankey D.
     Public Health Rep. 2011 Jul-Aug;126 Suppl 2:60-9.


152. Compliance with recommended dosing intervals for HPV vaccination among females, 13-17 years, National Immunization Survey-Teen, 2008-2009
     Dorell CG, Stokley S, Yankey D, Markowitz LE.
     Vaccine. 2011 Nov 22.


153. Hepatitis A vaccination coverage among adolescents in the United States
     Dorell CG, Yankey D, Byrd KK, Murphy TV.
     Pediatrics. 2012 Jan 23.


154. Hepatitis A vaccination coverage among adolescents in the United States
     Dorell CG, Yankey D, Byrd KK, Murphy TV.
     Pediatrics. 2012 Jan 23.


155. Hepatitis A vaccination coverage among adolescents in the United States
     Dorell CG, Yankey D, Byrd KK, Murphy TV.
     Pediatrics. 2012 Feb;129(2):213-21.


156. Vaccination and risk of type 1 diabetes mellitus in active component U.S. military, 2002-2008
     Duderstadt SK, Rose CE, Real TM, Sabatier JF, Stewart B, Ma G, Yerubandi UD, Eick AA, Tokars JI, McNeil MM.
     Vaccine. 2011 Nov 7.


157. A survey of US travelers to Asia to assess compliance with recommendations for the use of Japanese encephalitis vaccine
     Duffy MR, Reed C, Edelson PJ, Blumensaadt S, Crocker K, Griggs A, Biggerstaff BJ, Delorey MJ, Hayes EB, Fischer M.
     J Travel Med. 2013 May;20(3):165-70.


158. Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States--National Health and Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact?
     Dunne EF, Sternberg M, Markowitz LE, McQuillan G, Swan D, Patel S, Unger ER.
     J Infect Dis. 2011 Aug;204(4):562-5.


159. Rates and correlates of influenza vaccination among HIV-infected adults in the HIV Outpatient Study (HOPS), USA, 1999-2008
     Durham MD, Buchacz K, Armon C, Patel P, Wood K, Brooks JT.
     Prev Med. 2011 May 4.


160. A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity
     Edupuganti S, Eidex RB, Keyserling H, Akondy RS, Lanciotti R, Orenstein W, Del Rio C, Pan Y, Querec T, Lipman H, Barrett A, Ahmed R, Teuwen D, Cetron M, Mulligan MJ.
     Am J Trop Med Hyg. 2012 Dec 3.


161. Maternal influenza vaccination and effect on influenza virus infection in young infants
     Eick AA, Uyeki TM, Klimov A, Hall H, Reid R, Santosham M, O'Brien KL.
     Arch Pediatr Adolesc Med. 2010 Oct 4.


162. Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate
     Eko FO, Okenu DN, Singh UP, He Q, Black C, Igietseme JU.
     Vaccine. 2011 May 12;29(21):3802-10.


163. MF59(TM) as a vaccine adjuvant: a review of safety and immunogenicity
     El Sahly H.
     Expert Rev Vaccines. 2010 Oct;9(10):1135-41.


164. Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008
     Esposito DH, Tate JE, Kang G, Parashar UD.
     Clin Infect Dis. 2011 Jan;52(2):171-7.


165. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine administered according to an alternative dosing schedule compared with the standard dosing schedule in healthy women aged 15 to 25 years: results from a randomized study
     Esposito S, Birlutiu V, Jarcuska P, Perino A, Man SC, Vladareanu R, Meric D, et al.
     Pediatr Infect Dis J. 2011 Mar;30(3):e49-e55.


166. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers
     Esposito S, Tansey S, Thompson A, Razmpour A, Liang J, Jones TR, Ferrera G, et al.
     Clin Vaccine Immunol. 2010 Jun;17(6):1017-26.


167. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial
     Estivariz CF, Jafari H, Sutter RW, John TJ, Jain V, Agarwal A, Verma H, Pallansch MA, Singh AP, Guirguis S, Awale J, Burton A, Bahl S, Chatterjee A, Aylward RB.
     Lancet Infect Dis. 2011 Nov 7.


168. Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary
     Estivariz CF, Molnar Z, Venczel L, Kapusinszky B, Zingeser JA, Lipskaya GY, Kew OM, Berencsi G, Csohan A.
     Am J Epidemiol. 2011 Aug 1;174(3):316-25.


169. Poliovirus vaccination options for achieving eradication and securing the endgame
     Estivariz CF, Pallansch MA, Anand A, Wassilak SG, Sutter RW, Wenger JD, Orenstein WA.
     Curr Opin Virol. 2013 Jun 8.


170. Cincinnati pediatricians' measured and reported immunizing behavior for children during the national shortages of pneumococcal conjugate vaccine
     Fairbrother G, Donauer S, Staat MA, Broder K, Salisbury S, Morrow AL, Tabangin ME, Altaye M, Holloway M, Schwartz B.
     Vaccine. 2013 Apr 19;31(17):2177-83.


171. Rapid decline in presentations for genital warts after the implementation of a national quadrivalent human papillomavirus vaccination program for young women
     Fairley C, Hocking J, Gurrin L, Chen M, Donovan B, Bradshaw C.
     Sex Transm Infect. 2009 .


172. Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi
     Farr SL, Nelson JA, Ng'ombe TJ, Kourtis AP, Chasela C, Johnson JA, Kashuba AD, Tegha GL, Wiener J, Eron JJ, Banda HN, Mpaso M, Lipscomb J, Matiki C, Fiscus SA, Jamieson DJ, van der Horst C.
     J Acquir Immune Defic Syndr. 2010 Aug 15;54(5):515-23.


173. Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guerin (BCG) vaccines from different sources, Kazakhstan
     Favorov M, Ali M, Tursunbayeva A, Aitmagambetova I, Kilgore P, Ismailov S, Chorba T.
     PLoS One. 2012 ;7(3):e32567.


174. Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge
     Fay MP, Follmann DA, Lynn F, Schiffer JM, Stark GV, Kohberger R, Quinn CP, Nuzum EO.
     Sci Transl Med. 2012 Sep 12;4(151):151ra126.


175. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya
     Feikin DR, Laserson KF, Ojwando J, Nyambane G, Ssempijja V, Audi A, Nyakundi D, Oyieko J, Dallas MJ, Ciarlet M, Neuzil KM, Breiman RF.
     Vaccine. 2012 Apr 27;30 Suppl 1:A52-60.


176. Influenza vaccination status is not associated with influenza testing among children: implications for observational studies of vaccine effectiveness
     Ferdinands JM, Belongia EA, Nwasike C, Shay DK.
     Vaccine. 2011 Jan 7.


177. Inactivated influenza vaccines for prevention of community-acquired pneumonia: the limits of using nonspecific outcomes in vaccine effectiveness studies
     Ferdinands JM, Gargiullo P, Haber M, Moore M, Belongia EA, Shay DK.
     Epidemiology. 2013 Jul;24(4):530-7.


178. Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination
     Ferdinands JM, Shay DK.
     Clin Infect Dis. 2011 Nov 17.


179. Seasonal influenza vaccines
     Fiore AE, Bridges CB, Cox NJ.
     Curr Top Microbiol Immunol. 2009 ;333:43-82.


180. Expanding the recommendations for annual influenza vaccination to school-age children in the United States
     Fiore AE, Epperson S, Perrotta D, Bernstein H, Neuzil K.
     Pediatrics. 2012 Mar;129 Suppl 2:S54-62.


181. 2009 influenza A(H1N1) monovalent vaccines for children
     Fiore AE, Neuzil KM.
     JAMA. 2009 Dec 21.


182. Use of the emergency Incident Command System for school-located mass influenza vaccination clinics
     Fishbane M, Kist A, Schieber RA.
     Pediatrics. 2012 Mar;129 Suppl 2:S101-6.


183. Pandemic H1N1 influenza surveillance in Haiti, July-December 2009
     Fitter DL, Freeman NM, Buteau J, Magloire R, Sessions WM, Guo L, Katz MA, Boncy J.
     Influenza Other Respi Viruses. 2012 Nov 30.


184. Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil's national immunization program
     Flannery B, Samad S, de Moraes JC, Tate JE, Danovaro-Holliday MC, de Oliveira LH, Rainey JJ.
     Vaccine. 2013 Jan 10.


185. The case test-negative design for studies of the effectiveness of seasonal influenza vaccine
     Foppa IM, Haber M, Ferdinands JM, Shay DK.
     Vaccine. 2013 Apr 23.


186. Safety of the HPV bivalent and quadrivalent vaccines during pregnancy
     Forinash AB, Yancey AM, Pitlick JM, Myles TD.
     Ann Pharmacother. 2011 Feb 1.


187. Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi
     Fowlkes A, Witte D, Beeler J, Audet S, Garcia P, Curns A, Yang C, Fudzulani R, Broadhead R, Bellini WJ, Cutts F, Helfand RF.
     J Infect Dis. 2011 Jul;204 Suppl 1:S149-57.


188. Investigation of an outbreak of hypersensitivity-type reactions during the 2004 national measles-mumps-rubella vaccination campaign in Brazil
     Freitas DR, Moura E, Araujo G, Cardoso A, Scheidt P, Ferraz E, Madalosso G, Chen RT, Hatch DL.
     Vaccine. 2013 Jan 30;31(6):950-4.


189. Varicella vaccine safety and immunogenicity in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids
     Frenck Jr RW, Seward JF.
     Arthritis Care Res (Hoboken). 2010 Jul;62(7):903-6.


190. The effectiveness of varicella vaccine in China
     Fu C, Wang M, Liang J, Xu J, Wang C, Bialek S.
     Pediatr Infect Dis J. 2010 Aug;29(8):690-3.


191. Improving the quality of immunization delivery to an at-risk population: a comprehensive approach
     Fu LY, Weissman M, McLaren R, Thomas C, Campbell J, Mbafor J, Doshi U, Cora-Bramble D.
     Pediatrics. 2012 Feb;129(2):e496-503.


192. Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries
     Garcia S, Lagos R, Munoz A, Picon T, Rosa R, Alfonso A, Abriata G, Gentile A, Romanin V, Regueira M, Chiavetta L, Agudelo CI, Castaneda E, De la Hoz F, Higuera AB, Arce P, Cohen AL, Verani J, Zuber P, Gabastou JM, Pastor D, Flannery B, Andrus J.
     Vaccine. 2012 Jan 5;30(2):486-92.


193. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women
     Garcia-Sicilia J, Schwarz TF, Carmona A, Peters K, Malkin JE, Tran PM, Behre U, et al.
     J Adolesc Health. 2010 Feb;46(2):142-51.


194. Attitudes of pediatricians and primary health center physicians in India concerning routine immunization, barriers to vaccination, and missed opportunities to vaccinate
     Gargano LM, Thacker N, Choudhury P, Weiss PS, Pazol K, Bahl S, Jafari HS, Arora M, Orenstein WA, Hughes JM, Omer SB.
     Pediatr Infect Dis J. 2012 Feb;31(2):e37-42.


195. Effect of rotavirus vaccine on diarrhea mortality in different socioeconomic regions of Mexico
     Gastanaduy PA, Sanchez-Uribe E, Esparza-Aguilar M, Desai R, Parashar UD, Patel M, Richardson V.
     Pediatrics. 2013 Mar 4.


196. Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink
     Gee J, Naleway A, Shui I, Baggs J, Yin R, Li R, Kulldorff M, Lewis E, Fireman B, Daley MF, Klein NP, Weintraub ES.
     Vaccine. 2011 Sep 7.


197. Impact of rotavirus vaccination: the importance of monitoring strains
     Gentsch JR, Parashar UD, Glass RI.
     Future Microbiol. 2009 Dec;4:1231-4.[Request a copy via DocExpress]
     


198. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data
     Gershman MD, Staples JE, Bentsi-Enchill AD, Breugelmans JG, Brito GS, Bastoscamacho LA, Cottin P, Domingo C, Durbin A, Gascon J, Guenaneche F, Hayes EB, Jelenik Z, Khromava A, Martins RD, Wilson MM, Massy N, Nasidi A, Niedrig M, Sherwat A, Tsai T, Vilella A, Wilson ME, Kohl KS.
     Vaccine. 2012 May 3.


199. Detection of anti-yellow fever virus immunoglobulin M antibodies at 3-4 years following yellow fever vaccination
     Gibney KB, Edupuganti S, Panella AJ, Kosoy OI, Delorey MJ, Lanciotti RS, Mulligan MJ, Fischer M, Staples JE.
     Am J Trop Med Hyg. 2012 Oct 29.


200. Parental and societal values for the risks and benefits of childhood combination vaccines
     Gidengil C, Lieu TA, Payne K, Rusinak D, Messonnier M, Prosser LA.
     Vaccine. 2012 May 14;30(23):3445-52.


201. Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data
     Gidudu J, Sack DA, Pina M, Hudson MJ, Kohl KS, Bishop P, Chatterjee A, Chiappini E, Compingbutra A, da Costa C, Fernandopulle R, Fischer TK, Haber P, Masana W, de Menezes MR, Kang G, Khuri-Bulos N, Killion LA, Nair C, Poerschke G, Rath B, Salazar-Lindo E, Setse R, Wenger P, Wong VC, Zaman K.
     Vaccine. 2010 Dec 2.


202. Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data
     Gidudu JF, Walco GA, Anna Taddio A, Zempsky WT, Halperin SA, Calugar A, Gibbs NA, Hennig R, Jovancevic M, Netterlid E, O'Connor T, Oleske JM, Varricchio F, Tsai TF, Seifert H, Schuind AE.
     Vaccine. 2012 Apr 17.


203. Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice
     Giles BM, Bissel SJ, Craigo JK, Dealmeida DR, Wiley CA, Tumpey TM, Ross TM.
     J Virol. 2012 Feb;86(3):1500-13.


204. Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010
     Girard MP, Katz J, Pervikov Y, Palkonyay L, Kieny MP.
     Vaccine. 2010 Oct 4;28(42):6811-20.


205. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011
     Girard MP, Katz JM, Pervikov Y, Hombach J, Tam JS.
     Vaccine. 2011 Oct 13;29(44):7579-86.


206. Parental refusal of varicella vaccination and the associated risk of varicella infection in children
     Glanz JM, McClure DL, Magid DJ, Daley MF, France EK, Hambidge SJ.
     Arch Pediatr Adolesc Med. 2010 Jan;164(1):66-70.


207. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the Vaccine Safety Datalink
     Glanz JM, Newcomer SR, Hambidge SJ, Daley MF, Narwaney KJ, Xu S, Lee GM, Baggs J, Klein NP, Nordin JD, Naleway AL, Belongia EA, Weintraub ES.
     Arch Pediatr Adolesc Med. 2011 Aug;165(8):749-55.


208. A population-based cohort study of undervaccination in 8 managed care organizations across the United States
     Glanz JM, Newcomer SR, Narwaney KJ, Hambidge SJ, Daley MF, Wagner NM, McClure DL, Xu S, Rowhani-Rahbar A, Lee GM, Nelson JC, Donahue JG, Naleway AL, Nordin JD, Lugg MM, Weintraub ES.
     JAMA Pediatr. 2013 Mar 1;167(3):274-81.


209. Lessons from the US rotavirus vaccination program
     Glass RI, Patel M, Parashar U.
     JAMA. 2011 Oct 19;306(15):1701-2.


210. Toward optimal health: a review of vaccine recommendations for women. Interview by Jodi R Godfrey
     Godfrey JR, Jamieson DJ, Harpaz R, Markowitz LE.
     J Womens Health (Larchmt). 2009 Dec;18(12):1919-22.


211. Wakefield's article linking MMR vaccine and autism was fraudulent
     Godlee F, Smith J, Marcovitch H.
     BMJ. 2011 ;342:c7452.


212. Controversy undermines support for state mandates on the human papillomavirus vaccine
     Gollust SE, Dempsey AF, Lantz PM, Ubel PA, Fowler EF.
     Health Aff (Millwood). 2010 Nov;29(11):2041-6.


213. The interferon alpha/beta receptor provides protection against influenza virus replication but is dispensable for inflammatory response signaling
     Goodman AG, Zeng H, Proll SC, Peng X, Cilloniz C, Carter VS, Korth MJ, Tumpey TM, Katze MG.
     J Virol. 2009 Nov 25.


214. Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar
     Goodson JL, Kulkarni MA, Vanden Eng JL, Wannemuehler KA, Cotte AH, Desrochers RE, Randriamanalina B, Luman ET.
     Trop Med Int Health. 2012 Jan 24.


215. Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar
     Goodson JL, Kulkarni MA, Vanden Eng JL, Wannemuehler KA, Cotte AH, Desrochers RE, Randriamanalina B, Luman ET.
     Trop Med Int Health. 2012 Jan 24.


216. Rubella epidemiology in Africa in the prevaccine era, 2002-2009
     Goodson JL, Masresha B, Dosseh A, Byabamazima C, Nshimirimana D, Cochi S, Reef S.
     J Infect Dis. 2011 Jul;204 Suppl 1:S215-25.


217. Impact of a measles outbreak response immunization campaign: Maroua, Cameroon, 2009
     Goodson JL, Sosler S, Pasi O, Johnson T, Kobella M, Monono ME, Uzicanin A.
     J Infect Dis. 2011 Jul;204 Suppl 1:S252-9.


218. Impact of measles outbreak response vaccination campaign in Dar es Salaam, Tanzania
     Goodson JL, Wiesen E, Perry RT, Mach O, Kitambi M, Kibona M, Luman ET, Cairns KL.
     Vaccine. 2009 Aug 2.


219. Availability of human papillomavirus vaccine at medical practices in an area with elevated rates of cervical cancer
     Gottlieb SL, Brewer NT, Smith JS, Keating KM, Markowitz LE.
     J Adolesc Health. 2009 Nov;45(5):438-44.


220. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer
     Gottlieb SL, Brewer NT, Sternberg MR, Smith JS, Ziarnowski K, Liddon N, Markowitz LE.
     J Adolesc Health. 2009 Nov;45(5):430-7.


221. An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients--Arkansas, 2006
     Gould PL, Leung J, Scott C, Schmid DS, Deng H, Lopez A, Chaves SS, Reynolds M, Gladden L, Harpaz R, Snow S.
     Pediatr Infect Dis J. 2009 Aug;28(8):678-81.


222. Effects of immunizing school children with 2009 influenza A (H1N1) monovalent vaccine on absenteeism among students and teachers in Maine
     Graitcer SB, Dube NL, Basurto-Davila R, Smith PF, Ferdinands J, Thompson M, Uzicanin A, Gargiullo P, Chaves SS, Robinson S, Sears S, Tipton M, Monto AS, Mills D, Shay DK.
     Vaccine. 2012 May 17.


223. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States
     Grant LA, Dunne EF, Chesson H, Markowitz LE.
     Vaccine. 2011 Jan 27.


224. Response to a monovalent 2009 influenza A (H1N1) vaccine.
     Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, Basser RL.
     N Engl J Med. 2009 ;361(25):2405-13.


225. Near real-time vaccine safety surveillance with partially accrued data
     Greene SK, Kulldorff M, Yin R, Yih WK, Lieu TA, Weintraub ES, Lee GM.
     Pharmacoepidemiol Drug Saf. 2011 Jun;20(6):583-90.


226. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010
     Greene SK, Rett M, Weintraub ES, Li L, Yin R, Amato AA, Ho DT, Sheikh SI, Fireman BH, Daley MF, Belongia EA, Jacobsen SJ, Baxter R, Lieu TA, Kulldorff M, Vellozzi C, Lee GM.
     Am J Epidemiol. 2012 Jun 1;175(11):1100-9.


227. Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010
     Greene SK, Shay DK, Yin R, McCarthy NL, Baxter R, Jackson ML, Jacobsen SJ, Nordin JD, Irving SA, Naleway AL, Glanz JM, Lieu TA.
     Influenza Other Respi Viruses. 2012 Jun 11.


228. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities
     Griffin MR, Monto AS, Belongia EA, Treanor JJ, Chen Q, Chen J, Talbot HK, Ohmit SE, Coleman LA, Lofthus G, Petrie JG, Meece JK, Hall CB, Williams JV, Gargiullo P, Berman L, Shay DK.
     PLoS One. 2011 ;6(8):e23085.


229. Desirability and feasibility of a vaccine against cytomegalovirus
     Griffiths P, Plotkin S, Mocarski E, Pass R, Schleiss M, Krause P, Bialek S.
     Vaccine. 2013 Apr 18;31 Suppl 2:B197-203.


230. Assessing the effect of pneumococcal conjugate vaccines: what is the value of routinely collected surveillance data?
     Grijalva CG, Moore MR, Griffin MR.
     Lancet Infect Dis. 2011 Oct;11(10):724-6.


231. Influenza vaccination coverage among US nursing home nursing assistants: the role of working conditions
     Groenewold M, Baron S, Tak S, Allred N.
     J Am Med Dir Assoc. 2012 Jan;13(1):85 e17-23.


232. The impact of vaccination among American Indians--progress and challenges
     Groom AV.
     S D Med. 2013 ;Spec no:90-5.[Request a copy via DocExpress]
     


233. Vaccination coverage among American Indian and Alaska Native children, 2006-2010
     Groom AV, Santibanez TA, Bryan RT.
     Pediatrics. 2012 Nov 19.


234. Vaccination coverage among American Indian and Alaska Native children, 2006-2010
     Groom AV, Santibanez TA, Bryan RT.
     Pediatrics. 2012 Dec;130(6):e1592-9.


235. Differences in adult influenza vaccine-seeking behavior: the roles of race and attitudes
     Groom HC, Zhang F, Fisher AK, Wortley PM.
     J Public Health Manag Pract. 2013 May 24.


236. Assessing the interest to participate in a dengue vaccine efficacy trial among residents of Puerto Rico
     Guerra CL, Rodriguez-Acosta R, Soto-Gomez E, Zielinski-Gutierrez E, Pena-Orellana M, Santiago L, Rivera R, Cruz RR, Ramirez V, Tomashek K, Dayan G.
     Hum Vaccin Immunother. 2012 Jul 1;8(7).


237. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities
     Guerry SL, De Rosa CJ, Markowitz LE, Walker S, Liddon N, Kerndt PR, Gottlieb SL.
     Vaccine. 2011 Mar 9;29(12):2235-41.


238. Influenza vaccination guidelines and vaccine sales in southeast Asia: 2008-2011
     Gupta V, Dawood FS, Muangchana C, Lan PT, Xeuatvongsa A, Sovann L, Olveda R, Cutter J, Oo KY, Ratih TS, Kheong CC, Kapella BK, Kitsutani P, Corwin A, Olsen SJ.
     PLoS One. 2012 ;7(12):e52842.


239. Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics
     Gusarov I, Shatalin K, Starodubtseva M, Nudler E.
     Science. 2009 Sept 11;325(5946):1380-4.


240. Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets
     Gustin KM, Maines TR, Belser JA, van Hoeven N, Lu X, Dong L, Isakova-Sivak I, Chen LM, Voeten JT, Heldens JG, van den Bosch H, Cox NJ, Tumpey TM, Klimov AI, Rudenko L, Donis RO, Katz JM.
     J Infect Dis. 2011 Sep 28.


241. Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1-3, 2010
     Haaheim LR, Katz JM.
     Influenza Other Respi Viruses. 2011 Jul;5(4):288-95.


242. Risk of fetal death after pandemic influenza virus infection or vaccination
     Haberg SE, Trogstad L, Gunnes N, Wilcox AJ, Gjessing HK, Samuelsen SO, Skrondal A, Cappelen I, Engeland A, Aavitsland P, Madsen S, Buajordet I, Furu K, Nafstad P, Vollset SE, Feiring B, Nokleby H, Magnus P, Stoltenberg C.
     N Engl J Med. 2013 Jan 16.


243. Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years
     Hadler JL, Baker TN, Papadouka V, France AM, Zimmerman C, Livingston KA, Zucker JR.
     J Infect Dis. 2012 Jul;206(1):49-55.


244. Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type b vaccine experience
     Hajjeh R.
     Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2827-32.


245. Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experience
     Hajjeh RA, Privor-Dumm L, Edmond K, O'Loughlin R, Shetty S, Griffiths UK, Bear AP, Cohen AL, Chandran A, Schuchat A, Mulholland EK, Santosham M.
     Vaccine. 2010 Jul 23.


246. Algorithm to assess causality after individual adverse events following immunizations
     Halsey NA, Edwards KM, Dekker CL, Klein NP, Baxter R, Larussa P, Marchant C, Slade B, Vellozzi C.
     Vaccine. 2012 Aug 24;30(39):5791-5798.


247. Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness
     Hammitt LL, Bulkow LR, Singleton RJ, Nuorti JP, Hummel KB, Miernyk KM, Zanis C, Whaley M, Romero-Steiner S, Butler JC, Rudolph K, Hennessy TW.
     Vaccine. 2011 Jan 18.


248. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines
     Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A, Harrison LH, Lynfield R, Bennett NM, Petit S, Gershman K, Baumbach J, Beall B, Jorgensen J, Glennen A, Zell ER, Moore M.
     J Infect Dis. 2011 Dec 7.


249. Modeling the impact of RV144-like vaccines on HIV transmission
     Hankins CA, Glasser JW, Chen RT.
     Vaccine. 2011 Aug 18;29(36):6069-71.


250. Monitoring HPV vaccine impact: early results and ongoing challenges
     Hariri S, Markowitz L.
     J Infect Dis. 2012 Dec;206(11):1633-5.


251. Workplace efforts to promote influenza vaccination among healthcare personnel and their association with uptake during the 2009 pandemic influenza A (H1N1)
     Harris K, Maurer J, Black C, Euler G, Kadiyala S.
     Vaccine. 2011 Apr 5;29(16):2978-85.


252. The concept of vaccination failure
     Heininger U, Bachtiar NS, Bahri P, Dana A, Dodoo A, Gidudu J, Santos EM.
     Vaccine. 2012 Feb 8;30(7):1265-8.


253. Rules and tools that improved Vaccines for Children vaccine-ordering practices in Oregon: a 2010 pilot project
     Hewett R, Vancuren A, Trocio L, Beaudrault S, Gund A, Luther M, Groom H.
     J Public Health Manag Pract. 2013 Jan;19(1):9-15.


254. Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals
     Hickman CJ, Hyde TB, Sowers SB, Mercader S, McGrew M, Williams NJ, Beeler JA, Audet S, Kiehl B, Nandy R, Tamin A, Bellini WJ.
     J Infect Dis. 2011 Jul;204 Suppl 1:S549-58.


255. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009
     Hirth JM, Tan A, Wilkinson GS, Berenson AB.
     Cancer. 2012 Apr 27.


256. Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial
     Hirve S, Bavdekar A, Pandit A, Juvekar S, Patil M, Preziosi MP, Tang Y, Marchetti E, Martellet L, Findlow H, Elie C, Parulekar V, Plikaytis B, Borrow R, Carlone G, Kulkarni PS, Goel A, Suresh K, Beri S, Kapre S, Jadhav S, Preaud JM, Viviani S, Laforce FM.
     Vaccine. 2012 Oct 5;30(45):6456-60.


257. Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada
     Hoen AG, Buckeridge DL, Charland KM, Mandl KD, Quach C, Brownstein JS.
     CMAJ. 2011 Sep 20;183(13):E1025-32.


258. Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes
     Hoerger TJ, Schillie S, Wittenborn JS, Bradley CL, Zhou F, Byrd K, Murphy TV.
     Diabetes Care. 2013 Jan;36(1):63-9.


259. Compulsory vaccination, the Constitution, and the hepatitis B mandate for infants and young children
     Hollan M.
     Yale J Health Policy Law Ethics. 2012 Winter;12(1):39-86.[Request a copy via DocExpress]
     


260. Hepatitis E vaccine: not a moment too soon
     Holmberg SD.
     Lancet. 2010 Aug 20.


261. Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza
     Hossain MJ, Bourgeois M, Quan FS, Lipatov AS, Song JM, Chen LM, Compans RW, York I, Kang SM, Donis RO.
     Clin Vaccine Immunol. 2011 Oct 26.


262. Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007
     Hua W, Izurieta HS, Slade B, Belay ED, Haber P, Tiernan R, Woo EJ, Iskander J, Braun MM, Ball R.
     Pediatr Infect Dis J. 2009 Sep 12;28(11):943-7.


263. Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax)
     Huang CY, Kinney RM, Livengood JA, Bolling B, Arguello JJ, Luy BE, Silengo SJ, Boroughs KL, Stovall JL, Kalanidhi AP, Brault AC, Osorio JE, Stinchcomb DT.
     PLoS Negl Trop Dis. 2013 May;7(5):e2243.


264. Safety assessment of recalled Haemophilus influenzae type b (Hib) conjugate vaccines-United States, 2007-2008
     Huang WT, Chang S, Miller ER, Woo EJ, Hoffmaster AR, Gee JE, Clark TA, Iskander JK, Ball R, Broder KR.
     Pharmacoepidemiol Drug Saf. 2010 Jan 18.


265. Lack of association between acellular pertussis vaccine and seizures in early childhood
     Huang WT, Gargiullo PM, Broder KR, Weintraub ES, Iskander JK, Klein NP, Baggs JM.
     Pediatrics. 2010 Jul 19.


266. Analysis of variola and vaccinia neutralization assays for smallpox vaccines
     Hughes CM, Newman FK, Davidson WB, Olson VA, Smith SK, Holman RC, Yan L, Frey SE, Belshe RB, Karem KL, Damon IK.
     Clin Vaccine Immunol. 2012 May 16.


267. The impact of new vaccine introduction on immunization and health systems: a review of the published literature
     Hyde T, Dentz H, Wang S, Burchett H, Mounier-Jack S, Mantel C.
     Vaccine. 2012 Aug 28.


268. Chlamydia vaccines: recent developments and the role of adjuvants in future formulations
     Igietseme JU, Eko FO, Black CM.
     Expert Rev Vaccines. 2011 Nov;10(11):1585-96.


269. Role of T lymphocytes in the pathogenesis of chlamydia disease
     Igietseme JU, He Q, Joseph K, Eko FO, Lyn D, Ananaba G, Campbell A, Bandea C, Black CM.
     J Infect Dis. 2009 Aug 5;200(6):926-34.


270. Religious exemptions for immunization and risk of pertussis in New York State, 2000-2011
     Imdad A, Tserenpuntsag B, Blog DS, Halsey NA, Easton DE, Shaw J.
     Pediatrics. 2013 Jun 3.


271. Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort
     Irving SA, Donahue JG, Shay DK, Ellis-Coyle TL, Belongia EA.
     Vaccine. 2009 Nov 5;27(47):6546-9.


272. Trivalent inactivated influenza vaccine and spontaneous abortion
     Irving SA, Kieke BA, Donahue JG, Mascola MA, Baggs J, Destefano F, Cheetham TC, Jackson LA, Naleway AL, Glanz JM, Nordin JD, Belongia EA.
     Obstet Gynecol. 2013 Jan;121(1):159-165.


273. Vaccination site and risk of local reactions in children 1 through 6 years of age
     Jackson LA, Peterson D, Nelson JC, Marcy SM, Naleway AL, Nordin JD, Donahue JG, Hambidge SJ, Balsbaugh C, Baxter R, Marsh T, Madziwa L, Weintraub E.
     Pediatrics. 2013 Feb;131(2):283-9.


274. Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study
     Jackson LA, Yu O, Nelson J, Belongia EA, Hambidge SJ, Baxter R, Naleway A, Nordin J, Baggs J, Iskander J.
     Vaccine. 2009 Aug 6;27(36):4912-6.


275. The fifth dose of diphtheria and tetanus toxoids and acellular pertussis vaccine
     Jackson LA, Yu O, Nelson JC, Dominguez C, Peterson D, Baxter R, Hambidge SJ, et al.
     Pediatrics. 2011 Feb 7.


276. Injection site and risk of medically attended local reactions to acellular pertussis vaccine
     Jackson LA, Yu O, Nelson JC, Dominguez C, Peterson D, Baxter R, Hambidge SJ, Naleway AL, Belongia EA, Nordin JD, Baggs J.
     Pediatrics. 2011 Mar;127(3):e581-e587.


277. Hepatitis B vaccination coverage among U.S. adolescents, National Immunization Survey-Teen, 2006
     Jain N, Hennessey K.
     J Adolesc Health. 2009 Jun;44(6):561-7.


278. Determining accurate vaccination coverage rates for adolescents: the National Immunization Survey-Teen 2006
     Jain N, Singleton JA, Montgomery M, Skalland B.
     Public Health Rep. 2009 Sep-Oct;124(5):642-51.


279. Receipt of tetanus-containing vaccinations among adolescents aged 13 to 17 years in the United States: National Immunization Survey-Teen 2007
     Jain N, Stokley S, Cohn A.
     Clin Ther. 2010 Aug;32(8):1468-1478.


280. Benefits of influenza vaccination during pregnancy for pregnant women
     Jamieson DJ, Kissin DM, Bridges CB, Rasmussen SA.
     Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S17-20.


281. The safety of adjuvants in influenza vaccines during pregnancy: what do we know and why do we need them?
     Jamieson DJ, Rasmussen SA.
     Am J Obstet Gynecol. 2012 Sep;207(3):145-6.


282. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community
     Javanbakht M, Stahlman S, Walker S, Gottlieb S, Markowitz L, Liddon N, Plant A, Guerry S.
     Vaccine. 2012 Jun 22;30(30):4511-6.


283. Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011
     Jentes ES, Han P, Gershman MD, Rao SR, Larocque RC, Staples JE, Ryan ET.
     Am J Trop Med Hyg. 2013 Mar 4.


284. Rotavirus vaccines for global use: what are the remaining issues and challenges?
     Jiang B, Patel M, Parashar U.
     Hum Vaccin. 2010 May 12;6(5).


285. Does a monovalent inactivated rotavirus vaccine induce heterotypic immunity?: Evidence from animal studies
     Jiang B, Wang Y, Glass RI.
     Hum Vaccin Immunother. 2013 Jun 6;9(8).


286. Performance of rotavirus vaccines in developed and developing countries
     Jiang V, Jiang B, Tate J, Parashar UD, Patel MM.
     Hum Vaccin. 2010 Jul 21;6(7).


287. Human papillomavirus vaccination practices among providers in Indian Health Service, Tribal and Urban Indian healthcare facilities
     Jim CC, Wai-Yin Lee J, Groom AV, Espey DK, Saraiya M, Holve S, Bullock A, Howe J, Thierry J.
     J Womens Health (Larchmt). 2012 Feb 6.


288. Models of the impact of dengue vaccines: a review of current research and potential approaches
     Johansson MA, Hombach J, Cummings DA.
     Vaccine. 2011 Jun 20.


289. Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials
     John TJ, Jain H, Ravishankar K, Amaresh A, Verma H, Deshpande J, Pallansch MA, Singh AP, Sreevatsava M, Burton A, Malankar P, Chatterjee A, Sutter RW.
     Vaccine. 2011 Aug 5;29(34):5793-801.


290. From the CDC: new country-specific recommendations for pre-travel typhoid vaccination
     Johnson KJ, Gallagher NM, Mintz ED, Newton AE, Brunette GW, Kozarsky PE.
     J Travel Med. 2011 Nov;18(6):430-433.


291. Infectivity and vaccination efficacy studies in animal models of HBV S and pol gene mutants
     Kamili S.
     Antivir Ther. 2010 ;15(3 Pt B):477-85.


292. Toward the development of a hepatitis E vaccine
     Kamili S.
     Virus Res. 2011 May 18.


293. Pandemic (H1N1) 2009 and Hajj pilgrims who received predeparture vaccination, Egypt
     Kandeel A, Deming M, Kereem EA, El-Refay S, Afifi S, Abukela M, Earhart K, El-Sayed N, El-Gabaly H.
     Emerg Infect Dis. 2011 ;17(7):1266-1268.


294. Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage
     Kanitz EE, Wu LA, Giambi C, Strikas RA, Levy-Bruhl D, Stefanoff P, Mereckiene J, Appelgren E, D'Ancona F.
     Vaccine. 2012 Jul 27;30(35):5222-8.


295. Cost comparison of 2 mass vaccination campaigns against influenza A H1N1 in New York City
     Kansagra SM, McGinty MD, Morgenthau BM, Marquez ML, Rosselli-Fraschilla A, Zucker JR, Farley TA.
     Am J Public Health. 2012 Jul;102(7):1378-83.


296. Highly pathogenic (H5N1) avian influenza induces an inflammatory T helper type 1 cytokine response in the chicken
     Karpala AJ, Bingham J, Schat KA, Chen LM, Donis RO, Lowenthal JW, Bean AG.
     J Interferon Cytokine Res. 2011 Apr;31(4):393-400.


297. A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation
     Karras NA, Weeres M, Sessions W, Xu X, Defor T, Young JA, Stefanski H, Brunstein C, Cooley S, Miller JS, Blazar BR, Wagner JE, Verneris MR.
     Biol Blood Marrow Transplant. 2013 Jan;19(1):109-16.


298. Impact of 2-dose vaccination on varicella epidemiology: Connecticut--2005-2008
     Kattan JA, Sosa LE, Bohnwagner HD, Hadler JL.
     J Infect Dis. 2011 Jan 3.


299. 2009 pandemic influenza A vaccination of pregnant women-King County, Washington State, 2009-2010
     Kay MK, Koelemay KG, Kwan-Gett TS, Cadwell BL, Duchin JS.
     Am J Public Health. 2012 Jun;102 Suppl 3:S368-74.


300. Parental views of school-located delivery of adolescent vaccines
     Kelminson K, Saville A, Seewald L, Stokley S, Dickinson LM, Daley MF, Suh C, Kempe A.
     J Adolesc Health. 2012 Aug;51(2):190-6.


301. Adverse reactions to vaccines
     Kelso J, Li J, Nicklas R, Blessing-Moore J, Cox L, Lang D, Oppenheimer J, Portnoy J, Randolph C, Schuller D, Spector S, Tilles S, Wallace D, Ballas Z, Baker J, Bellanti J, Ein D, Grammer L.
     Ann Allergy Asthma Immunol. 2009 Oct;103(Suppl 2):S1-14.


302. Parental reports of adverse events following simultaneously given dT-IPV and MMR vaccines in healthy 9-year-old children
     Kemmeren JM, van der Maas NA, de Melker HE.
     Eur J Pediatr. 2010 Sep 21.


303. Effectiveness and cost of immunization recall at school-based health centers
     Kempe A, Barrow J, Stokley S, Saville A, Glazner JE, Suh C, Federico S, Abrams L, Seewald L, Beaty B, Daley MF, Dickinson LM.
     Pediatrics. 2012 May 7.


304. Effectiveness and cost of immunization recall at school-based health centers
     Kempe A, Barrow J, Stokley S, Saville A, Glazner JE, Suh C, Federico S, Abrams L, Seewald L, Beaty B, Daley MF, Dickinson LM.
     Pediatrics. 2012 May 7.


305. Adoption of rotavirus vaccination by pediatricians and family medicine physicians in the United States
     Kempe A, Patel MM, Daley MF, Crane LA, Beaty B, Stokley S, Barrow J, Babbel C, Dickinson LM, Tempte JL, Parashar UD.
     Pediatrics. 2009 Oct 12.


306. Pediatricians' attitudes about collaborations with other community vaccinators in the delivery of seasonal influenza vaccine
     Kempe A, Wortley P, O'Leary S, Crane LA, Daley MF, Stokley S, Babbel C, Dong F, Beaty B, Seewald L, Suh C, Dickinson LM.
     Acad Pediatr. 2011 Sep 5.


307. Confidence about vaccines in the United States: understanding parents' perceptions
     Kennedy A, Lavail K, Nowak G, Basket M, Landry S.
     Health Aff (Millwood). 2011 Jun;30(6):1151-9.


308. Limited awareness of vaccines recommended for adolescents and other results from two national consumer health surveys in the United States
     Kennedy A, Stokley S, Curtis CR, Gust D.
     J Adolesc Health. 2012 Feb;50(2):198-200.


309. Monitoring seasonal influenza vaccination coverage among pregnant women in the United States
     Kennedy ED, Ahluwalia IB, Ding H, Lu PJ, Singleton JA, Bridges CB.
     Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S9-S16.


310. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults
     Kennedy JS, Gurwith M, Dekker CL, Frey SE, Edwards KM, Kenner J, Lock M, Empig C, Morikawa S, Saijo M, Yokote H, Karem K, Damon I, Perlroth M, Greenberg RN.
     J Infect Dis. 2011 Nov;204(9):1395-402.


311. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?
     Kepka D, Berkowitz Z, Yabroff KR, Roland K, Saraiya M.
     Sex Transm Infect. 2012 Oct;88(6):433-5.


312. Long-term immune responses to Coxiella burnetii after vaccination
     Kersh GJ, Fitzpatrick KA, Self JS, Biggerstaff BJ, Massung RF.
     Clin Vaccine Immunol. 2012 Nov 28.


313. Supplementary immunization activities to achieve measles elimination: experience of the European Region
     Khetsuriani N, Deshevoi S, Goel A, Spika J, Martin R, Emiroglu N.
     J Infect Dis. 2011 Jul;204 Suppl 1:S343-52.


314. A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-uninfected East Africans (RV 172)
     Kibuuka H, Kimutai R, Maboko L, Sawe F, Schunk MS, Kroidl A, Shaffer D, Eller LA, Kibaya R, Eller MA, Schindler KB, Schuetz A, Millard M, Kroll J, Dally L, Hoelscher M, Bailer R, Cox JH, Marovich M, Birx DL, Graham BS, Michael NL, de Souza MS, Robb ML.
     J Infect Dis. 2010 Feb 15;201(4):600-7.


315. Measles outbreak in Burkina Faso, 2009: a case-control study to determine risk factors and estimate vaccine effectiveness
     Kidd S, Ouedraogo B, Kambire C, Kambou JL, McLean H, Kutty PK, Ndiaye S, Fall A, Alleman M, Wannemuehler K, Masresha B, Goodson JL, Uzicanin A.
     Vaccine. 2012 May 28.


316. Strategies to alleviate original antigenic sin responses to influenza viruses
     Kim JH, Davis WG, Sambhara S, Jacob J.
     Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13751-6.


317. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch
     Kim YC, Song JM, Lipatov AS, Choi SO, Lee JW, Donis RO, Compans RW, Kang SM, Prausnitz MR.
     Eur J Pharm Biopharm. 2012 Jun;81(2):239-47.


318. Attitudes and practices of obstetrician-gynecologists regarding influenza vaccination in pregnancy
     Kissin DM, Power ML, Kahn EB, Williams JL, Jamieson DJ, Macfarlane K, Schulkin J, Zhang Y, Callaghan WM.
     Obstet Gynecol. 2011 Nov;118(5):1074-80.


319. Vaccine safety in special populations
     Klein NP.
     Hum Vaccin. 2011 Feb 1;7(2).


320. Evaluation of immunization rates and safety among children with inborn errors of metabolism
     Klein NP, Aukes L, Lee J, Fireman B, Shapira SK, Slade B, Baxter R, Summar M.
     Pediatrics. 2011 May;127(5):e1139-46.


321. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures
     Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, Baxter R, Hambidge S, Nordin J, Naleway A, Belongia EA, Lieu T, Baggs J, Weintraub E.
     Pediatrics. 2010 Jul;126(1):e1-8.


322. Developing the next generation of vaccinologists
     Klein NP, Gidudu J, Qiang Y, Pahud B, Rowhani-Rahbar A, Baxter R, Dekker CL, Edwards KM, Halsey NA, Larussa P, Marchant C, Tokars JI, Destefano F.
     Vaccine. 2011 Nov 21;29(50):9296-7.


323. Measles-containing vaccines and febrile seizures in children age 4 to 6 years
     Klein NP, Lewis E, Baxter R, Weintraub E, Glanz J, Naleway A, Jackson LA, Nordin J, Lieu T, Belongia EA, Fireman B.
     Pediatrics. 2012 Apr 2.


324. Measles-containing vaccines and febrile seizures in children age 4 to 6 years
     Klein NP, Lewis E, Baxter R, Weintraub E, Glanz J, Naleway A, Jackson LA, Nordin J, Lieu T, Belongia EA, Fireman B.
     Pediatrics. 2012 Apr 2.


325. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies
     Klein NP, Ray P, Carpenter D, Hansen J, Lewis E, Fireman B, Black S, et al.
     Vaccine. 2009 Nov 5.


326. WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere influenza vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011
     Klimov AI, Garten R, Russell C, Barr IG, Besselaar TG, Daniels R, Engelhardt OG, Grohmann G, Itamura S, Kelso A, McCauley J, Odagiri T, Smith D, Tashiro M, Xu X, Webby R, Wang D, Ye Z, Yuelong S, Zhang W, Cox N.
     Vaccine. 2012 Oct 5;30(45):6461-71.


327. Neonatal vaccine-strain varicella zoster virus infection 22 days after maternal post-partum vaccination
     Kluthe M, Herrera A, Blanca H, Leung J, Bialek SR, Schmid DS.
     Pediatr Infect Dis J. 2012 May 8.


328. Provider chart audits and outreach to parents: impact in improving childhood immunization coverage and immunization information system completeness
     Kolasa MS, Lutz JP, Cofsky A, Jones T.
     J Public Health Manag Pract. 2009 Nov-Dec;15(6):459-63.


329. Hospitalizations for invasive pneumococcal disease among HIV-1-infected adolescents and adults in the United States in the era of highly active antiretroviral therapy and the conjugate pneumococcal vaccine
     Kourtis AP, Ellington S, Bansil P, Jamieson DJ, Posner SF.
     J Acquir Immune Defic Syndr. 2010 Jul 8.


330. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 A(H1N1) pandemic influenza viruses
     Krause JC, Tumpey TM, Huffman CJ, McGraw PA, Pearce MB, Tsibane T, Hai R, Basler CF, Crowe JE.
     J Virol. 2009 Dec 30.


331. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity
     Kristiansen PA, Diomande F, Ba AK, Sanou I, Ouedraogo AS, Ouedraogo R, Sangare L, Kandolo D, Ake F, Saga IM, Clark TA, Misegades L, Martin SW, Thomas JD, Tiendrebeogo SR, Hassan-King M, Djingarey MH, Messonnier NE, Preziosi MP, Laforce FM, Caugant DA.
     Clin Infect Dis. 2013 Feb;56(3):354-63.


332. Public health response to influenza A(H1N1) as an opportunity to build public trust
     Larson HJ, Heymann DL.
     JAMA. 2010 Jan 20;303(3):271-2.


333. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network
     LaRussa PS, Edwards KM, Dekker CL, Klein NP, Halsey NA, Marchant C, Baxter R, Engler RJ, Kissner J, Slade BA.
     Pediatrics. 2011 May;127 Suppl 1:S65-73.


334. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(R), in Kenya, including among HIV-infected and HIV-exposed infants
     Laserson KF, Nyakundi D, Feikin DR, Nyambane G, Cook E, Oyieko J, Ojwando J, Rivers SB, Ciarlet M, Neuzil KM, Breiman RF.
     Vaccine. 2012 Apr 27;30 Suppl 1:A61-70.


335. [Post vaccination rotavirus surveillance in Hungary, in 2007]
     Laszlo B, Czellar E, Deak J, Juhasz A, Kovacs J, Konya J, Meszaros J, Meszner Z, Mihaly I, Molnar P, Nyul Z, Patri L, Puskas E, Schneider F, Siffel C, Toth A, Toth E, Szucs G, Banyai K.
     Orv Hetil. 2009 Aug 2;150(31):1443-50.


336. Community-based values for 2009 pandemic influenza A H1N1 illnesses and vaccination-related adverse events
     Lavelle TA, Meltzer MI, Gebremariam A, Lamarand K, Fiore AE, Prosser LA.
     PLoS One. 2011 ;6(12):e27777.


337. Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine
     Lebaron CW, Forghani B, Matter L, Reef SE, Beck C, Bi D, Cossen C, Sullivan BJ.
     J Infect Dis. 2009 Aug 6;200(6):888-99.


338. Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246 and CMX001
     Lederman ER, Davidson W, Groff HL, Smith SK, Warkentien T, Li Y, Wilkins KA, Karem KL, Akondy RS, Ahmed R, Frace M, Shieh WJ, Zaki S, Hruby DE, Painter WP, Bergman KL, Cohen JI, Damon IK.
     J Infect Dis. 2012 Aug 16.


339. Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans
     Ledgerwood JE, Hu Z, Gordon IJ, Yamshchikov G, Enama ME, Plummer S, Bailer R, Pearce MB, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS.
     Clin Vaccine Immunol. 2012 Nov;19(11):1792-7.


340. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
     Ledgerwood JE, Wei CJ, Hu Z, Gordon IJ, Enama ME, Hendel CS, McTamney PM, Pearce MB, Yassine HM, Boyington JC, Bailer R, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS.
     Lancet Infect Dis. 2011 Dec;11(12):916-924.


341. H1N1 and seasonal influenza vaccine safety in the Vaccine Safety Datalink Project
     Lee GM, Greene SK, Weintraub ES, Baggs J, Kulldorff M, Fireman BH, Baxter R, Jacobsen SJ, Irving S, Daley MF, Yin R, Naleway A, Nordin JD, Li L, McCarthy N, Vellozzi C, Destefano F, Lieu TA.
     Am J Prev Med. 2011 Aug;41(2):121-8.


342. The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance
     Lee LA, Franzel L, Atwell J, Datta SD, Friberg IK, Goldie SJ, Reef SE, Schwalbe N, Simons E, Strebel PM, Sweet S, Suraratdecha C, Tam Y, Vynnycky E, Walker N, Walker DG, Hansen PM.
     Vaccine. 2013 Apr 18;31 Suppl 2:B61-72.


343. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
     Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsague X, Skinner SR, Apter D, Naud P, Salmeron J, Chow S, Kitchener H, Teixeira JC, Hedrick J, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, De Carvalho NS, Germar MJ, Peters K, Mindel A, De Sutter P, Bosch FX, David M, Descamps D, Struyf F, Dubin G.
     Lancet Oncol. 2011 Nov 9.


344. Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the Vaccine Adverse Event Reporting System
     Leroy Z, Broder K, Menschik D, Shimabukuro T, Martin D.
     Vaccine. 2012 Mar 2;30(11):2020-3.


345. Acceptability of human papillomavirus vaccine for males: a review of the literature
     Liddon N, Hood J, Wynn BA, Markowitz LE.
     J Adolesc Health. 2010 Feb;46(2):113-23.


346. Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: findings from the 2006-2008 National Survey of Family Growth
     Liddon NC, Hood J, Leichliter JS.
     Vaccine. 2012 Feb 15.


347. Human papillomavirus vaccine and sexual behavior among adolescent and young women
     Liddon NC, Leichliter JS, Markowitz LE.
     Am J Prev Med. 2012 Jan;42(1):44-52.


348. Safety and reactogenicity of DTPa-HBV-IPV/Hib and DTPa-IPV/I-Hib vaccines in a post-marketing surveillance setting
     Lim FS, Phua KB, Lee BW, Quak SH, Teoh YL, Ramakrishnan G, Han HH, et al.
     Southeast Asian J Trop Med Public Health. 2011 Jan;42(1):138-47.


349. Multiple vaccinations and the risk of medically attended fever
     Lin ND, Kleinman K, Chan KA, Soumerai S, Mehta J, Mullooly JP, Shay DK, Kolczak M, Lieu TA.
     Vaccine. 2010 Jun 7;28(25):4169-74.


350. Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009
     Lindley MC, Smith PJ, Rodewald LE.
     Public Health Rep. 2011 Jul-Aug;126 Suppl 2:124-34.


351. Measurement of influenza vaccination coverage among healthcare personnel in US hospitals
     Lindley MC, Yonek J, Ahmed F, Perz JF, Williams Torres G.
     Infect Control Hosp Epidemiol. 2009 Oct 22.


352. Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009
     Lindsey NP, Staples JE, Jones JF, Sevjar JJ, Griggs A, Iskander J, Miller ER, Fischer M.
     Vaccine. 2010 Oct 20.


353. Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era
     Lopez AS, Zhang J, Brown C, Bialek S.
     Pediatrics. 2011 Jan 3.


354. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States
     Lopman BA, Curns AT, Yen C, Parashar UD.
     J Infect Dis. 2011 Oct;204(7):980-6.


355. Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011
     Lopman BA, Payne DC, Tate JE, Patel MM, Cortese MM, Parashar UD.
     Curr Opin Virol. 2012 Jun 29.


356. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings
     Lopman BA, Pitzer VE, Sarkar R, Gladstone B, Patel M, Glasser J, Gambhir M, Atchison C, Grenfell BT, Edmunds WJ, Kang G, Parashar UD.
     PLoS One. 2012 ;7(8):e41720.


357. Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: demand, supply and seasonality
     Lorick SA, Fishbein D, Weintraub E, Wortley PM, Lee GM, Zhou F, Davis R.
     BMC Infect Dis. 2009 ;9:175.


358. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
     Loughlin AM, Marchant CD, Adams W, Barnett E, Baxter R, Black S, Casey C, Dekker C, Edwards KM, Klein J, Klein NP, Larussa P, Sparks R, Jakob K.
     Vaccine. 2012 Nov 26;30(50):7253-9.


359. 2009 pandemic influenza A (H1N1) and vaccine failure in pregnancy
     Louie JK, Wadford DA, Norman A, Jamieson DJ.
     Obstet Gynecol. 2011 Feb;117(2 Pt 2):470-2.


360. Vaccine administration decision making: the case of yellow fever vaccine
     Lown BA, Chen LH, Wilson ME, Sisson E, Gershman M, Yanni E, Jentes ES, Hochberg NS, Hamer DH, Barnett ED.
     Clin Infect Dis. 2012 Sep;55(6):837-43.


361. Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-2005
     Lowrance DW, Ndamage F, Kayirangwa E, Ndagije F, Lo W, Hoover DR, Hanson J, Elul B, Ayaba A, Ellerbrock T, Rukundo A, Shumbusho F, Nash D, Mugabo J, Assimwe A.
     J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):49-55.


362. A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China
     Lu L, Suo L, Li J, Zhai L, Zheng Q, Pang X, Bialek SR, Wang C.
     Vaccine. 2012 Jul 20;30(34):5094-8.


363. Hepatitis A vaccination coverage among adults 18-49 years traveling to a country of high or intermediate endemicity, United States
     Lu PJ, Byrd KK, Murphy TV.
     Vaccine. 2013 Mar 20.


364. Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009
     Lu PJ, Byrd KK, Murphy TV, Weinbaum C.
     Vaccine. 2011 Jul 20.


365. H1N1 and seasonal influenza vaccination of U.S. healthcare personnel, 2010
     Lu PJ, Ding H, Black CL.
     Am J Prev Med. 2012 Sep;43(3):282-92.


366. A comparison of parent and provider reported influenza vaccination status of adolescents
     Lu PJ, Dorell C, Yankey D, Santibanez TA, Singleton JA.
     Vaccine. 2012 Mar 20.


367. Influenza, hepatitis B, and tetanus vaccination coverage among health care personnel in the United States
     Lu PJ, Euler GL.
     Am J Infect Control. 2011 Jan 31.


368. Influenza vaccination among adults with asthma findings from the 2007 BRFSS survey
     Lu PJ, Euler GL, Callahan DB.
     Am J Prev Med. 2009 Aug;37(2):109-15.


369. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008
     Lu PJ, Euler GL, Harpaz R.
     Am J Prev Med. 2011 Feb;40(2):e1-6.


370. Influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination among adults 25 to 64 years of age with high-risk conditions-United States, 2010
     Lu PJ, Gonzalez-Feliciano A, Ding H, Bryan LN, Yankey D, Monsell EA, Greby SM, Euler GL.
     Am J Infect Control. 2013 Feb 15.


371. Meningococcal conjugate vaccination among adolescents aged 13-17 years, United States, 2007
     Lu PJ, Jain N, Cohn AC.
     Vaccine. 2009 Dec 28.


372. Uptake of pneumococcal polysaccharide vaccination among working-age adults with underlying medical conditions, United States, 2009
     Lu PJ, Nuorti JP.
     Am J Epidemiol. 2012 Apr 15;175(8):827-37.


373. Pneumococcal polysaccharide vaccination among adults aged 65 years and older, U.S., 1989-2008
     Lu PJ, Pekka Nuorti J.
     Am J Prev Med. 2010 Oct;39(4):287-95.


374. Human papillomavirus vaccine initiation and awareness: U.S. young men in the 2010 National Health Interview Survey
     Lu PJ, Williams WW, Li J, Dorell C, Yankey D, Kepka D, Dunne EF.
     Am J Prev Med. 2013 Apr;44(4):330-8.


375. Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in Vietnam
     Luan le T, Trang NV, Phuong NM, Nguyen HT, Ngo HT, Tran HB, Dang HN, Dang AD, Gentsch JR, Wang Y, Esona MD, Glass RI, Steele AD, Kilgore PE, Nguyen MV, Jiang B, Nguyen HD.
     Vaccine. 2009 Nov 20;27 Suppl 5:F130-8.


376. Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States
     Lucero CA, Hageman J, Zell ER, Bulens S, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Fridkin SK, Active Bacterial Core Surveillance MRSA Investigators.
     Vaccine. 2009 Aug 13;27(37):5061-8.


377. Building on success: should other health services be integrated into the immunization platform?
     Luman ET, Dietz V, Andrus JK, Binkin N.
     J Infect Dis. 2012 Mar;205 Suppl 1:NP.


378. Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine
     MacNeil JR, Cohn AC, Zell ER, Schmink S, Miller E, Clark T, Messonnier NE.
     Pediatr Infect Dis J. 2011 Jan 4.


379. Challenges in confirming a varicella outbreak in the two-dose vaccine era
     Mahamud A, Wiseman R, Grytdal S, Basham C, Asghar J, Dang T, Leung J, Lopez A, Schmid DS, Bialek SR.
     Vaccine. 2012 Aug 7.


380. Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years
     Manoff SB, Liss C, Caulfield MJ, Marchese RD, Silber J, Boslego J, Romero-Steiner S, Rajam G, Glass NE, Whitney CG, Carlone GM.
     J Infect Dis. 2010 Feb 15;201(4):525-33.


381. Near elimination of varicella deaths in the US after implementation of the vaccination program
     Marin M, Zhang JX, Seward JF.
     Pediatrics. 2011 Jul 25.


382. Post-licensure monitoring of HPV vaccine in the United States
     Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF.
     Vaccine. 2010 Feb 24.


383. Human papillomavirus vaccine introduction - the first five years
     Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, Brotherton JM.
     Vaccine. 2012 Nov 20;30 Suppl 5:F139-48.


384. Health equity: the challenge
     Marmot M.
     Aust N Z J Public Health. 2012 Dec;36(6):513-4.


385. Generation of Trypanosoma cruzi-specific CD8+ T-cell immunity is unaffected by the absence of type I interferon signaling
     Martin DL, Murali-Krishna K, Tarleton RL.
     Infect Immun. 2010 Jul;78(7):3154-9.


386. Inequity in childhood immunization in India: a systematic review
     Mathew JL.
     Indian Pediatr. 2012 Mar;49(3):203-23.


387. Support for seasonal influenza vaccination requirements among US healthcare personnel
     Maurer J, Harris KM, Black CL, Euler GL.
     Infect Control Hosp Epidemiol. 2012 Mar;33(3):213-21.


388. Perceived seriousness of seasonal and A(H1N1) influenzas, attitudes toward vaccination, and vaccine uptake among U.S. adults: does the source of information matter?
     Maurer J, Uscher-Pines L, Harris KM.
     Prev Med. 2010 May 24.


389. Physician attitudes regarding school-located vaccinations
     McCormick EV, Durfee J, Vogt TM, Daley MF, Hambidge SJ, Shlay J.
     Pediatrics. 2012 Oct 1.


390. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose
     McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, Bulkow L, Fiore AE, Bell BP, Hennessy TW.
     J Infect Dis. 2009 Sep 28;200(9):1390-6.


391. A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination - possible stimulated reporting?
     McNeil MM, Arana J, Stewart B, Hartshorn M, Hrncir D, Wang H, Lamias M, Locke M, Stamper J, Tokars JI, Engler RJ.
     Vaccine. 2012 Feb 3.


392. Risk of fatal adverse events after H1N1 influenza vaccine: limitations of passive surveillance data
     McNeil MM, Broder KR, Vellozzi C, Destefano F.
     Clin Infect Dis. 2010 Oct 1;51(7):871-2.


393. Who is unlikely to report adverse events after vaccinations to the vaccine adverse event reporting system (VAERS)?
     McNeil MM, Li R, Pickering S, Real TM, Smith PJ, Pemberton MR.
     Vaccine. 2013 Apr 15.


394. Optimizing influenza vaccine distribution
     Medlock J, Galvani AP.
     Science. 2009 Sep 25;325(5948):1705-8.


395. Human papillomavirus vaccination history among women with precancerous cervical lesions: disparities and barriers
     Mehta NR, Julian PJ, Meek JI, Sosa LE, Bilinski A, Hariri S, Markowitz LE, Hadler JL, Niccolai LM.
     Obstet Gynecol. 2012 Mar;119(3):575-81.


396. HPV vaccine implementation in STD clinics - STD Surveillance Network
     Meites E, Llata E, Hariri S, Zenilman J, Longfellow L, Schwebke J, Tabidze I, Mettenbrink C, Jenkins H, Guerry S, Pathela P, Asbel L, Stover JA, Bernstein K, Kerani RP, Dunne EF, Markowitz LE.
     Sex Transm Dis. 2012 Jan;39(1):32-34.


397. Vaccine preventable diseases and vaccination policy for indigenous populations
     Menzies RI, Singleton RJ.
     Pediatr Clin North Am. 2009 Dec;56(6):1263-83.


398. Prenatal care providers and influenza prevention and treatment: lessons from the field
     Mersereau PW, Layton CM, Smith LR, Kendrick JS, Mitchell EW, Amoozegar JB, Williams JL.
     Matern Child Health J. 2012 Feb;16(2):479-85.


399. Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in Alaska native adults 55-70 years of age
     Miernyk KM, Butler JC, Bulkow LR, Singleton RJ, Hennessy TW, Dentinger CM, Peters HV, Knutsen B, Hickel J, Parkinson AJ.
     Clin Infect Dis. 2009 Jul 15;49(2):241-8.


400. Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature
     Miles M, Ryman TK, Dietz V, Zell E, Luman ET.
     Vaccine. 2012 Nov 26.


401. Increases in vaccination coverage of healthcare personnel following institutional requirements for influenza vaccination: a national survey of US hospitals
     Miller BL, Ahmed F, Lindley MC, Wortley PM.
     Vaccine. 2011 Sep 21.


402. Institutional requirements for influenza vaccination of healthcare personnel: results from a nationally representative survey of acute care hospitals--United States, 2011
     Miller BL, Ahmed F, Lindley MC, Wortley PM.
     Clin Infect Dis. 2011 Dec;53(11):1051-9.


403. US hospital requirements for pertussis vaccination of healthcare personnel, 2011
     Miller BL, Ahmed F, Lindley MC, Wortley PM.
     Infect Control Hosp Epidemiol. 2011 Dec;32(12):1209-12.


404. Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults-United States, 2005-2007
     Miller BL, Kretsinger K, Euler GL, Lu PJ, Ahmed F.
     Vaccine. 2011 Mar 31.


405. Student immunity requirements of health professional schools: vaccination and other means of fulfillment-United States, 2008
     Miller BL, Lindley MC, Ahmed F, Wortley PM.
     Infect Control Hosp Epidemiol. 2011 Sep;32(9):908-11.


406. Evaluation of rotavirus vaccines in Asia--are there lessons to be learnt?
     Mirzayeva R, Steele AD, Parashar UD, Zaman K, Neuzil KM, Nelson EA.
     Vaccine. 2009 Nov 20;27 Suppl 5:F120-9.


407. Estimating the effectiveness of acellular pertussis vaccines
     Misegades LK, Martin SW, Messonnier NE, Clark TA.
     Clin Infect Dis. 2012 Aug 7.


408. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010
     Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, Martin SW.
     JAMA. 2012 Nov 28;308(20):2126-32.


409. Genetic characterization of bulgarian rotavirus isolates and detection of rotavirus variants: challenges for the rotavirus vaccine program?
     Mladenova Z, Iturriza-Gomara M, Esona MD, Gray J, Korsun N.
     J Med Virol. 2011 Feb;83(2):348-56.


410. Fractional doses of inactivated poliovirus vaccine in Oman
     Mohammed AJ, AlAwaidy S, Bawikar S, Kurup PJ, Elamir E, Shaban MM, Sharif SM, van der Avoort HG, Pallansch MA, Malankar P, Burton A, Sreevatsava M, Sutter RW.
     N Engl J Med. 2010 Jun 24;362(25):2351-9.


411. Comparative efficacy of inactivated and live attenuated influenza vaccines
     Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E, Rotthoff J, Boulton M, Victor JC.
     N Engl J Med. 2009 Sep 24;361(13):1260-7.


412. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch
     Moon S, Wang Y, Edens C, Gentsch JR, Prausnitz MR, Jiang B.
     Vaccine. 2012 Nov 19.


413. Differential profiles and inhibitory effect on rotavirus vaccines of non-antibody components in breast milk from mothers in developing and developed countries
     Moon SS, Tate JE, Ray P, Dennehy PH, Archary D, Coutsoudis A, Bland R, Newell ML, Glass RI, Parashar U, Jiang B.
     Pediatr Infect Dis J. 2013 Apr 11.


414. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines
     Moon SS, Wang Y, Shane AL, Nguyen T, Ray P, Dennehy P, Baek LJ, Parashar U, Glass RI, Jiang B.
     Pediatr Infect Dis J. 2010 May 3.


415. Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010
     Moro PL, Arana J, Cano M, Menschik D, Yue X, Lewis P, Haber P, Martin D, Broder K.
     Clin Infect Dis. 2012 Mar 22.


416. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009
     Moro PL, Broder K, Zheteyeva Y, Walton K, Rohan P, Sutherland A, Guh A, Haber P, Destefano F, Vellozzi C.
     Am J Obstet Gynecol. 2010 Oct 19.


417. Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy
     Moro PL, Tepper NK, Grohskopf LA, Vellozzi C, Broder K.
     Expert Rev Vaccines. 2012 Aug;11(8):911-21.


418. Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010
     Moro PL, Yue X, Lewis P, Haber P, Broder K.
     Vaccine. 2011 Sep 13.


419. Adverse events following trivalent inactivated influenza vaccination in children: analysis of the Vaccine Adverse Event Reporting System
     Muhammad RD, Haber P, Broder KR, Leroy Z, Ball R, Braun MM, Davis RL, McMahon AW.
     Pediatr Infect Dis J. 2010 Oct 29.


420. Wheezing lower respiratory disease and vaccination of premature infants
     Mullooly JP, Schuler R, Mesa J, Drew L, Destefano F.
     Vaccine. 2011 Oct 13;29(44):7611-7617.


421. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults
     Musher DM, Manof SB, Liss C, McFetridge RD, Marchese RD, Bushnell B, Alvarez F, et al.
     J Infect Dis. 2010 Feb 15;201(4):516-24.


422. Infection and treatment immunizations for successful parasite vaccines
     Mutapi F, Billingsley PF, Secor WE.
     Trends Parasitol. 2013 Mar;29(3):135-41.


423. Reported adverse events in young women following quadrivalent human papillomavirus vaccination
     Naleway AL, Gold R, Drew L, Riedlinger K, Henninger ML, Gee J.
     J Womens Health (Larchmt). 2012 Apr;21(4):425-32.


424. Poliovirus vaccines: past, present, and future
     Nathanson N, Kew OM.
     Arch Pediatr Adolesc Med. 2011 Jun;165(6):489-90.


425. Evolution of the pediatric influenza vaccination program in the United States
     Neuzil KM, Fiore AE, Schieber RA.
     Pediatrics. 2012 Mar;129 Suppl 2:S51-3.


426. Rotavirus vaccines for children in developing countries: understanding the science, maximizing the impact, and sustaining the effort
     Neuzil KM, Parashar UD, Steele AD.
     Vaccine. 2012 Apr 27;30 Suppl 1:A1-2.


427. Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in Philadelphia, Pennsylvania, 2006
     Nguyen MD, Perella D, Watson B, Marin M, Renwick M, Spain CV.
     Pediatr Infect Dis J. 2010 Mar 29.


428. Tdap and GBS letter
     Nordin JD, Yih WK, Kulldorff M, Weintraub E.
     Vaccine. 2011 Feb 1;29(6):1122.


429. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data
     Novak RT, Kambou JL, Diomande FV, Tarbangdo TF, Ouedraogo-Traore R, Sangare L, Lingani C, Martin SW, Hatcher C, Mayer LW, Laforce FM, Avokey F, Djingarey MH, Messonnier NE, Tiendrebeogo SR, Clark TA.
     Lancet Infect Dis. 2012 Jul 17.


430. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak
     Ogbuanu IU, Kutty PK, Hudson JM, Blog D, Abedi GR, Goodell S, Lawler J, McLean HQ, Pollock L, Rausch-Phung E, Schulte C, Valure B, Armstrong GL, Gallagher K.
     Pediatrics. 2012 Nov 5.


431. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt
     Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, et al.
     PLoS Med. 2010 ;7(5):e1000270.


432. Influenza vaccine effectiveness in the community and the household
     Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, Monto AS.
     Clin Infect Dis. 2013 May;56(10):1363-9.


433. Global use of Haemophilus influenzae type b conjugate vaccine
     Ojo LR, O'Loughlin RE, Cohen AL, Loo JD, Edmond KM, Shetty SS, Bear AP, Privor-Dumm L, Griffiths UK, Hajjeh R.
     Vaccine. 2010 Aug 3.


434. Physicians' confidence in vaccine safety studies
     O'Leary ST, Allison MA, Stokley S, Crane LA, Hurley LP, Beaty B, Kempe A.
     Prev Med. 2013 Mar;56(3-4):231-3.


435. Adherence to expanded influenza immunization recommendations among primary care providers
     O'Leary ST, Crane LA, Wortley P, Daley MF, Hurley LP, Dong F, Stokley S, Babbel CI, Seewald L, Gahm C, Dickinson LM, Kempe A.
     J Pediatr. 2012 Mar;160(3):480-486 e1.


436. Adoption of rotavirus vaccine by U.S. physicians: progress and challenges
     O'Leary ST, Parashar UD, Crane LA, Allison MA, Stokley S, Beaty BL, Brtnikova M, Hurley LP, Kempe A.
     Am J Prev Med. 2013 Jan;44(1):56-62.


437. Influenza vaccination in the 2009-2010 pandemic season: the experience of primary care physicians
     O'Leary ST, Stokley S, Crane LA, Allison MA, Hurley LP, Wortley P, Babbel CI, Beaty BL, Gahm C, Kempe A.
     Prev Med. 2012 Jul;55(1):68-71.


438. Methodology and measurement of the effectiveness of Haemophilus influenzae type b vaccine: systematic review
     O'Loughlin RE, Edmond K, Mangtani P, Cohen AL, Shetty S, Hajjeh R, Mulholland K.
     Vaccine. 2010 Aug 31;28(38):6128-36.


439. Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: results from a randomized, blinded, controlled trial
     Omer SB, Zaman K, Roy E, Arifeen SE, Raqib R, Noory L, Seib K, Breiman RF, Steinhoff MC.
     J Infect Dis. 2013 Apr;207(7):1144-7.


440. Generation and characterization of candidate vaccine viruses for prepandemic influenza vaccines
     O'Neill E, Donis RO.
     Curr Top Microbiol Immunol. 2009 ;333:83-108.


441. Measles: the burden of preventable deaths
     Orenstein WA, Hinman AR.
     Lancet. 2012 Jun 9;379(9832):2130-1.


442. Assessing parents' knowledge and attitudes towards seasonal influenza vaccination of children before and after a seasonal influenza vaccination effectiveness study in low-income urban and rural Kenya, 2010--2011
     Oria PA, Arunga G, Lebo E, Wong JM, Emukule G, Muthoka P, Otieno N, Mutonga D, Breiman RF, Katz MA.
     BMC Public Health. 2013 Apr 25;13(1):391.


443. Are Kenyan healthcare workers willing to receive the pandemic influenza vaccine? Results from a cross-sectional survey of healthcare workers in Kenya about knowledge, attitudes and practices concerning infection with and vaccination against 2009 pandemic influenza A (H1N1), 2010
     Oria PA, Matini W, Nelligan I, Emukule G, Scherzer M, Oyier B, Ochieng HN, Hooper L, Kanyuga A, Muthoka P, Morales KF, Nzioka C, Breiman RF, Katz MA.
     Vaccine. 2011 Feb 3.


444. Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
     Osorio JE, Huang CY, Kinney RM, Stinchcomb DT.
     Vaccine. 2011 Sep 23;29(42):7251-60.


445. Trends in compliance with two-dose influenza vaccine recommendations among children aged 6 months through 8 years
     Pabst LJ, Chaves SS, Weinbaum C.
     Vaccine. 2013 May 15.


446. Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination
     Pahud BA, Williams SE, Dekker CL, Halsey N, Larussa P, Baxter RP, Klein NP, Marchant CD, Sparks RC, Jakob K, Aukes L, Swope S, Barnett E, Lewis P, Berger M, Dreskin SC, Donofrio PD, Sejvar JJ, Slade BA, Gidudu J, Vellozzi C, Edwards KM.
     Pediatr Infect Dis J. 2013 Feb;32(2):163-168.


447. A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed
     Pajewski NM, Shrestha S, Quinn CP, Parker SD, Wiener H, Aissani B, McKinney BA, Poland GA, Edberg JC, Kimberly RP, Tang J, Kaslow RA.
     Vaccine. 2012 Jul 6;30(32):4778-84.


448. Enterovirus 71 encephalitis: a new vaccine on the horizon?
     Pallansch MA, Oberste MS.
     Lancet. 2013 March;381(9871):976-977.


449. Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine
     Pandey A, Singh N, Vemula SV, Couetil L, Katz JM, Donis R, Sambhara S, Mittal SK.
     PLoS One. 2012 ;7(3):e33428.


450. Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis
     Panozzo CA, Stockman LJ, Curns AT, Anderson LJ.
     Pediatrics. 2010 Jun 14.


451. Progress with rotavirus vaccines: summary of the Tenth International Rotavirus Symposium
     Parashar U, Steele D, Neuzil K, Quadros C, Tharmaphornpilas P, Serhan F, Santosham M, Patel M, Glass R.
     Expert Rev Vaccines. 2013 Feb;12(2):113-7.


452. Invasive pneumococcal infections among vaccinated children in the United States
     Park SY, Van Beneden CA, Pilishvili T, Martin M, Facklam RR, Whitney CG, for the Active Bacterial Core surveillance team.
     J Pediatr. 2009 Dec 2.


453. Stockpiling antiviral drugs for the next influenza pandemic
     Patel A, Gorman SE.
     Clin Pharmacol Ther. 2009 Sep;86(3):241-3.


454. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy
     Patel M, Glass R, Jiang B, Santosham M, Lopman B, Parashar U.
     J Infect Dis. 2013 Apr 17.


455. Duration of protection of pentavalent rotavirus vaccination in Nicaragua
     Patel M, Pedreira C, De Oliveira LH, Umana J, Tate J, Lopman B, Sanchez E, Reyes M, Mercado J, Gonzalez A, Perez MC, Balmaceda A, Andrus J, Parashar U.
     Pediatrics. 2012 Aug;130(2):e365-72.


456. Oral rotavirus vaccines: how well will they work where they are needed most?
     Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI.
     J Infect Dis. 2009 Nov 1;200 Suppl 1:S39-48.


457. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines
     Patel M, Steele AD, Parashar UD.
     Vaccine. 2012 Apr 27;30 Suppl 1:A30-5.


458. Rotavirus vaccination programmes
     Patel MM.
     BMJ. 2012 ;345:e5286.


459. Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis
     Patel MM, Clark AD, Sanderson CF, Tate J, Parashar UD.
     PLoS Med. 2012 Oct;9(10):e1001330.


460. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?
     Patel MM, Glass R, Desai R, Tate JE, Parashar UD.
     Lancet Infect Dis. 2012 Jul;12(7):561-70.


461. Intussusception and rotavirus vaccination: a review of the available evidence
     Patel MM, Haber P, Baggs J, Zuber P, Bines JE, Parashar UD.
     Expert Rev Vaccines. 2009 Nov;8(11):1555-64.


462. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil
     Patel MM, Lopez-Collada VR, Bulhoes MM, De Oliveira LH, Bautista Marquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, Hernandez-Hernandez Ldel C, Toledo-Cortina G, Ceron-Rodriguez M, Osnaya-Romero N, Martinez-Alcazar M, Aguinaga-Villasenor RG, Plascencia-Hernandez A, Fojaco-Gonzalez F, Hernandez-Peredo Rezk G, Gutierrez-Ramirez SF, Dorame-Castillo R, Tinajero-Pizano R, Mercado-Villegas B, Barbosa MR, Maluf EM, Ferreira LB, de Carvalho FM, dos Santos AR, Cesar ED, de Oliveira ME, Silva CL, de Los Angeles Cortes M, Ruiz Matus C, Tate J, Gargiullo P, Parashar UD.
     N Engl J Med. 2011 Jun 16;364(24):2283-92.


463. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs
     Patel MM, Parashar UD.
     J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9.


464. The rotavirus experience in Mexico: discovery to control
     Patel MM, Parashar UD, Santosham M, Richardson V.
     Clin Infect Dis. 2012 Dec 27.


465. Real-world impact of rotavirus vaccination
     Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD.
     Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S1-5.


466. The impact of indirect benefits of vaccination on postlicensure vaccine effectiveness estimates: a scenario analysis
     Patel MM, Tate J, Cortese M, Payne D, Armstrong G, Parashar UD, Lopman B.
     Vaccine. 2010 Sep 24.


467. Does Tdap vaccination interfere with serodiagnosis of pertussis infection?
     Pawloski LC, Kirkland KB, Baughman AL, Martin MD, Talbot EA, Messonnier NE, Tondella ML.
     Clin Vaccine Immunol. 2012 Apr 25.


468. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years old, 2009-2011
     Payne DC, Boom JA, Staat MA, Edwards KM, Szilagyi PG, Klein EJ, Selvarangan R, Azimi PH, Harrison C, Moffatt M, Johnston SH, Sahni LC, Baker CJ, Rench MA, Donauer S, McNeal M, Chappell J, Weinberg GA, Tasslimi A, Tate JE, Wikswo M, Curns AT, Sulemana I, Mijatovic-Rustempasic S, Esona MD, Bowen MD, Gentsch JR, Parashar UD.
     Clin Infect Dis. 2013 Mar 13.


469. A multi-center, qualitative assessment of pediatrician and maternal perspectives on rotavirus vaccines and the detection of Porcine circovirus
     Payne DC, Humiston S, Opel D, Kennedy A, Wikswo M, Downing K, Klein EJ, Kobayashi A, Locke D, Albertin C, Chesley C, Staat MA.
     BMC Pediatr. 2011 ;11:83.


470. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US counties, 2006-2009
     Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, Hall CB, Chappell J, Curns AT, Wikswo M, Tate JE, Lopman BA, Parashar UD.
     Clin Infect Dis. 2011 Jun 23.


471. Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program
     Payne DC, Szilagyi PG, Staat MA, Edwards KM, Gentsch JR, Weinberg GA, Hall CB, Curns AT, Clayton H, Griffin MR, Fairbrother G, Parashar UD.
     Pediatr Infect Dis J. 2009 Nov;28(11):948-953.


472. Support for universal childhood vaccination against influenza among private pediatric clinics and public health departments in Georgia
     Pazol K, Prill MM, Gazmararian JA, O'Malley EM, Jelks D, Coleman MS, Hinman AR, Orenstein WA.
     J Public Health Manag Pract. 2009 Sep-Oct;15(5):393-400.


473. Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus in ferrets
     Pearce MB, Belser JA, Gustin KM, Pappas C, Houser KV, Sun X, Maines TR, Pantin-Jackwood MJ, Katz JM, Tumpey TM.
     J Virol. 2012 May 2.


474. Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets
     Pearce MB, Belser JA, Houser KV, Katz JM, Tumpey TM.
     Vaccine. 2011 Feb 18.


475. Strategies to vaccinate against cancer of the cervix: feasibility of a school-based HPV vaccination program in Peru
     Penny M, Bartolini R, Mosqueira NR, Lamontagne DS, Mendoza MA, Ramos I, Winkler JL, Villafana J, Janmohamed A, Jumaan AO.
     Vaccine. 2011 Jul 12;29(31):5022-30.


476. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America
     Pickering LK, Baker CJ, Freed GL, Gall SA, Grogg SE, Poland GA, Rodewald LE, Schaffner W, Stinchfield P, Tan L, Zimmerman RK, Orenstein WA.
     Clin Infect Dis. 2009 Aug 6;49(6):817-40.


477. Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization
     Pierson DL, Mehta SK, Gilden D, Cohrs RJ, Nagel MA, Schmid DS, Tyring SK.
     J Infect Dis. 2011 Jun;203(11):1542-5.


478. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine
     Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, Smith PJ, Beall BW, Whitney CG, Moore MR.
     J Infect Dis. 2009 Nov 30.


479. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine
     Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, Smith PJ, Beall BW, Whitney CG, Moore MR, Active Bacterial Core Surveillance/Emerging Infections Program Network.
     J Infect Dis. 2010 Jan 1;201(1):32-41.


480. Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism
     Plante K, Wang E, Partidos CD, Weger J, Gorchakov R, Tsetsarkin K, Borland EM, Powers AM, Seymour R, Stinchcomb DT, Osorio JE, Frolov I, Weaver SC.
     PLoS Pathog. 2011 Jul;7(7):e1002142.


481. Practice and child characteristics associated with influenza vaccine uptake in young children
     Poehling KA, Fairbrother G, Zhu Y, Donauer S, Ambrose S, Edwards KM, Staat MA, Prill MM, Finelli L, Allred NJ, Bardenheier B, Szilagyi PG.
     Pediatrics. 2010 Oct;126(4):665-73.


482. Impact of maternal immunization on influenza hospitalizations in infants
     Poehling KA, Szilagyi PG, Staat MA, Snively BM, Payne DC, Bridges CB, Chu SY, Light LS, Prill MM, Finelli L, Griffin MR, Edwards KM.
     Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S141-8.


483. Impact of maternal immunization on influenza hospitalizations in infants
     Poehling KA, Szilagyi PG, Staat MA, Snively BM, Payne DC, Bridges CB, Chu SY, Light LS, Prill MM, Finelli L, Griffin MR, Edwards KM.
     Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S141-8.


484. Vaccines against Lyme disease: what happened and what lessons can we learn?
     Poland GA.
     Clin Infect Dis. 2011 Feb;52 Suppl 3:s253-8.


485. Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation
     Poli F, Overeem S, Lammers GJ, Plazzi G, Lecendreux M, Bassetti CL, Dauvilliers Y, Keene D, Khatami R, Li Y, Mayer G, Nohynek H, Pahud B, Paiva T, Partinen M, Scammell TE, Shimabukuro T, Sturkenboom M, van Dinther K, Wiznitzer M, Bonhoeffer J.
     Vaccine. 2013 Jan 30;31(6):994-1007.


486. Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
     Pomfret TC, Gagnon JM, Gilchrist AT.
     J Clin Pharm Ther. 2011 Feb;36(1):1-9.


487. Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions
     Powell SE, Hariri S, Steinau M, Bauer HM, Bennett NM, Bloch KC, Niccolai LM, Schafer S, Unger ER, Markowitz LE.
     Vaccine. 2012 Nov 5.


488. Recommended adult immunization schedule: United States, 2010
     Advisory Committee on Immunization Practices.
     Ann Intern Med. 2010 Jan 5;152(1):36-9.


489. Recommended adult immunization schedule: United States, 2012
     Advisory Committee on Immunization Practices..
     Ann Intern Med. 2012 Jan 31.


490. Expanding and improving urban outreach immunization in Patna, India
     Pradhan N, Ryman TK, Varkey S, Ranjan A, Gupta SK, Krishna G, Swetanki RP, Young R.
     Trop Med Int Health. 2011 Dec 14.


491. National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008
     Centers for Disease Control and Prevention.
     MMWR Morb Mortal Wkly Rep. 2009 Sep 18;58(36):997-1001.


492. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies-recommendations of the Advisory Committee on Immunization Practice
     Centers for Disease Control and Prevention.
     Ann Emerg Med. 2010 Jul;56(1):64-7.


493. Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses
     Price GE, Soboleski MR, Lo CY, Misplon JA, Pappas C, Houser KV, Tumpey TM, Epstein SL.
     Vaccine. 2009 Sep 1;27(47):6512-21.


494. Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses
     Price GE, Soboleski MR, Lo CY, Misplon JA, Quirion MR, Houser KV, Pearce MB, Pappas C, Tumpey TM, Epstein SL.
     PLoS ONE. 2010 ;5(10):e13162.


495. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States
     Prosser LA, Lavelle TA, Fiore AE, Bridges CB, Reed C, Jain S, Dunham KM, Meltzer MI.
     PLoS One. 2011 ;6(7):e22308.


496. Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years
     Prosser LA, Meltzer MI, Fiore A, Epperson S, Bridges CB, Hinrichsen V, Lieu TA.
     Arch Pediatr Adolesc Med. 2010 Oct 4.


497. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials
     Prymula R, Siegrist CA, Chlibek R, Zemlickova H, Vackova M, Smetana J, Lommel P, Kaliskova E, Borys D, Schuerman L.
     Lancet. 2009 Oct 20;374(9698):1339-50.


498. Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus
     Pushko P, Kort T, Nathan M, Pearce MB, Smith G, Tumpey TM.
     Vaccine. 2010 Jul 5;28(30):4771-6.


499. Adolescents' perspectives on vaccination outside the traditional medical home: a survey of urban middle and high school students
     Pyrzanowski J, Curtis CR, Crane LA, Barrow J, Beaty B, Kempe A, Daley MF.
     Clin Pediatr (Phila). 2013 Apr;52(4):329-37.


500. Molecular studies of the Oka varicella vaccine
     Quinlivan M, Breuer J, Schmid DS.
     Expert Rev Vaccines. 2011 Sep;10(9):1321-36.


501. Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster
     Quinlivan ML, Jensen NJ, Radford KW, Schmid DS.
     J Clin Microbiol. 2012 Feb 29.


502. A three dose intramuscular schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long term protection against inhalation anthrax in rhesus macaques
     Quinn CP, Sabourin CL, Niemuth NA, Li H, Semenova VA, Rudge TL, Mayfield HJ, Schiffer J, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Brys AM, Hunt RE, Levesque D, Estep JE, Barnewall RE, Robinson DM, Plikaytis BD, Marano N.
     Clin Vaccine Immunol. 2012 Aug 29.


503. Long-term immunogenicity of hepatitis A vaccine in Alaska 17 years after initial childhood series
     Raczniak GA, Bulkow L, Bruce MG, Zanis C, Baum R, Snowball M, Byrd KK, Sharapov UM, Hennessy TW, McMahon BJ.
     J Infect Dis. 2012 Nov 29.


504. Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children
     Raczniak GA, Thomas T, Bulkow L, Negus S, Zanis C, Bruce MG, Spradling PR, Teshale EH, McMahon BJ.
     Vaccine. 2013 Mar 4.


505. Providing monovalent oral polio vaccine type 1 to newborns: Findings from a pilot birth-dose project in Moradabad district, India
     Rainey JJ, Bhatnagar P, Estivariz CF, Durrani S, Galway M, Sandhu H, Bahl S, Jafari H, Wenger J.
     Bull World Health Organ. 2009 December;87(12):955-959.


506. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination
     Rainey JJ, Danovaro-Holliday MC, Magloire R, Kananda G, Lee CE, Chamouillet H, Lacapere F, Mung K, Luman ET.
     J Infect Dis. 2011 Sep;204 Suppl 2:S616-21.


507. Vaccination coverage in Haiti: results from the 2009 national survey
     Rainey JJ, Lacapere F, Danovaro-Holliday MC, Mung K, Magloire R, Kananda G, Cadet JR, Lee CE, Chamouillet H, Luman E.
     Vaccine. 2012 Jan 3.


508. Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: findings from a systematic review of the published literature, 1999-2009
     Rainey JJ, Watkins M, Ryman TK, Sandhu P, Bo A, Banerjee K.
     Vaccine. 2011 Sep 2.


509. An augmented passive immune therapy to treat fulminant bacterial infections
     Rajam G, Sampson J, Carlone GM, Ades EW.
     Recent Pat Antiinfect Drug Discov. 2010 Jun 1;5(2):157-67.


510. Parent and adolescent perspectives about adolescent vaccine delivery: practical considerations for vaccine communication
     Rand CM, Humiston SG, Schaffer SJ, Albertin CS, Shone LP, Blumkin AK, Stokley S, Szilagyi PG.
     Vaccine. 2011 Oct 13;29(44):7651-8.


511. Cytoplasmic nucleic acid sensors in antiviral immunity
     Ranjan P, Bowzard JB, Schwerzmann JW, Jeisy-Scott V, Fujita T, Sambhara S.
     Trends Mol Med. 2009 Aug 6;15(8):359-68.


512. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age
     Ray P, Black S, Shinefield H, Dillon A, Carpenter D, Lewis E, Ross P, Chen RT, Klein NP, Baxter R.
     Vaccine. 2011 Sep 2;29(38):6592-6597.


513. Immunosenescence and challenges of vaccination against influenza in the aging population
     Reber AJ, Chirkova T, Kim JH, Cao W, Biber R, Shay DK, Sambhara S.
     Aging Dis. 2012 Feb;3(1):68-90.


514. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine
     Reed C, Meltzer MI, Finelli L, Fiore A.
     Vaccine. 2012 Jan 4.


515. Reducing the global burden of congenital rubella syndrome
     Reef SE, Chu SY, Cochi SL, Kezaala R, van den Ent M, Gay A, de Quadros C, Strebel PM.
     Lancet. 2012 Sep 29;380(9848):1145-6.


516. Safety, tolerability, and immunogenicity of gardasil given concomitantly with menactra and adacel
     Reisinger KS, Block SL, Collins-Ogle M, Marchant C, Catlett M, Radley D, Sings HL, et al.
     Pediatrics. 2010 Jun;125(6):1142-51.


517. Parents' health beliefs and HPV vaccination of their adolescent daughters
     Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS.
     Soc Sci Med. 2009 Aug;69(3):475-80.


518. How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen
     Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS.
     Vaccine. 2009 Nov 16;27(49):6840-4.


519. Statewide HPV vaccine initiation among adolescent females in North Carolina
     Reiter PL, Cates JR, McRee AL, Gottlieb SL, Shafer A, Smith JS, Brewer NT.
     Sex Transm Dis. 2010 Sep;37(9):549-56.


520. HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure
     Reiter PL, McRee AL, Gottlieb SL, Brewer NT.
     Vaccine. 2010 Aug 31;28(38):6292-7.


521. Correlates of receiving recommended adolescent vaccines among adolescent females in North Carolina
     Reiter PL, McRee AL, Gottlieb SL, Brewer NT.
     Hum Vaccin. 2011 Jan 1;7(1).


522. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
     Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH, the Moph-Taveg Investigators.
     N Engl J Med. 2009 Oct 20.


523. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico
     Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, Parashar U, Patel M.
     N Engl J Med. 2010 Jan 28;362(4):299-305.


524. Childhood diarrhea deaths after rotavirus vaccination in Mexico
     Richardson V, Parashar U, Patel M.
     N Engl J Med. 2011 Aug 25;365(8):772-3.


525. Seroconversion following incomplete human rabies postexposure prophylaxis
     Robertson K, Recuenco S, Niezgoda M, Garcia ER, Rupprecht CE.
     Vaccine. 2010 Jul 13.


526. Sick-visit immunizations and delayed well-baby visits
     Robison SG.
     Pediatrics. 2013 Jun 3.


527. Frequency of alternative immunization schedule use in a metropolitan area
     Robison SG, Groom H, Young C.
     Pediatrics. 2012 Jul;130(1):32-8.


528. Estimating the vaccine-preventable burden of hospitalized pneumonia among young Mozambican children
     Roca A, Sigauque B, Quinto L, Morais L, Berenguera A, Corachan M, Ribo JL, Naniche D, Bassat Q, Sacoor C, Nhalungo D, Macete E, Schuchat A, Soriano-Gabarro M, Flannery B, Alonso PL.
     Vaccine. 2010 Jul 5;28(30):4851-7.


529. Vaccinating adolescents--new evidence of challenges and opportunities
     Rodewald LE, Orenstein WA.
     J Adolesc Health. 2009 Nov;45(5):427-9.


530. Immune response after rabies vaccine in a kidney transplant recipient
     Rodriguez-Romo R, Morales-Buenrostro LE, Lecuona L, Escalante-Santillan N, Velasco-Villa A, Kuzmin I, Rupprecht CE, De-Leo C, Ramirez J, Alberu J.
     Transpl Infect Dis. 2011 Aug 26.


531. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children
     RTS, S Clinical Trials Partnership.
     N Engl J Med. 2011 Nov 17;365(20):1863-75.


532. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants
     RTS .
     N Engl J Med. 2012 Dec 13;367(24):2284-95.


533. Integration of routine vaccination and hygiene interventions: a comparison of 2 strategies in Kenya
     Ryman TK, Briere EC, Cartwright E, Schlanger K, Wannemuehler KA, Russo ET, Kola S, Sadumah I, Nygren BL, Ochieng C, Quick R, Watkins ML.
     J Infect Dis. 2012 Mar;205 Suppl 1:S65-76.


534. Contribution of Immunization Weeks toward improving coverage, access to services, and completion of recommended childhood vaccinations in Assam, India
     Ryman TK, Trakroo A, Ekka JB, Watkins M.
     Vaccine. 2012 Feb 7.


535. Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination
     Sable SB, Cheruvu M, Nandakumar S, Sharma S, Bandyopadhyay K, Kellar KL, Posey JE, Plikaytis BB, Amara RR, Shinnick TM.
     PLoS One. 2011 ;6(7):e22718.


536. The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations
     Said MA, O'Brien KL, Nuorti JP, Singleton R, Whitney CG, Hennessy TW.
     Vaccine. 2011 Jul 26;29(33):5355-62.


537. Rural parents' vaccination-related attitudes and intention to vaccinate middle and high school children against influenza following educational influenza vaccination intervention
     Sales JM, Painter JE, Pazol K, Gargano LM, Orenstein W, Hughes JM, Diclemente RJ.
     Hum Vaccin. 2011 Nov 1;7(11).


538. Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis
     Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N.
     Lancet. 2013 Apr 27;381(9876):1461-8.


539. Immunosenescence and influenza vaccine efficacy
     Sambhara S, McElhaney JE.
     Curr Top Microbiol Immunol. 2009 ;333:413-29.


540. Improving influenza vaccines
     Sambhara S, Rappuoli R.
     Expert Rev Vaccines. 2012 Aug;11(8):871-2.


541. Behavior and beliefs about influenza vaccine among adults aged 50-64 years
     Santibanez TA, Mootrey GT, Euler GL, Janssen AP.
     Am J Health Behav. 2010 Jan-Feb;34(1):77-89.


542. Effects of a nationwide Hib vaccine shortage on vaccination coverage in the United States
     Santibanez TA, Shefer A, Briere EC, Cohn A, Groom AV.
     Vaccine. 2011 Nov 29.


543. Rotavirus vaccine--a powerful tool to combat deaths from diarrhea
     Santosham M.
     N Engl J Med. 2010 Jan 28;362(4):358-60.


544. HPV vaccine effect: is the glass half full or half empty?
     Saraiya M, Hariri S.
     Lancet. 2011 Jun 18;377(9783):2057-8.


545. Cancers that U.S. physicians believe the HPV vaccine prevents: findings from a physician survey, 2009
     Saraiya M, Rosser JI, Cooper CP.
     J Womens Health (Larchmt). 2012 Jan 4.


546. Getting under the hood: exploring issues that affect provider-based recall using an immunization information system
     Saville AW, Albright K, Nowels C, Barnard J, Daley MF, Stokley S, Irby K, Kempe A.
     Acad Pediatr. 2011 January - February;11(1):44-49.


547. Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System
     Schatz M, Chambers CD, Jones KL, Louik C, Mitchell AA.
     Am J Obstet Gynecol. 2011 Feb 17.


548. Early experience conducting school-located vaccination programs for seasonal influenza
     Schieber RA, Kennedy A, Kahn EB.
     Pediatrics. 2012 Mar;129 Suppl 2:S68-74.


549. Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review
     Schillie SF, Murphy TV.
     Vaccine. 2012 Dec 17.


550. Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature
     Schillie SF, Spradling PR, Murphy TV.
     Diabetes Care. 2012 Dec;35(12):2690-7.


551. Antibody persistence in mothers one year after pneumococcal immunization in pregnancy
     Schlaudecker EP, Steinhoff MC, Omer SB, Roy E, Arifeen SE, Dodd CN, Altaye M, Raqib R, Breiman RF, Zaman K.
     Vaccine. 2012 Jul 20;30(34):5063-6.


552. Impact of varicella vaccine on varicella-zoster virus dynamics
     Schmid DS, Jumaan AO.
     Clin Microbiol Rev. 2010 Jan;23(1):202-17.


553. Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine
     Schmidt MA, Crane B, Mullooly JP, Naleway AL.
     Vaccine. 2010 Sep 25.


554. Next generation dengue vaccines: a review of candidates in preclinical development
     Schmitz J, Roehrig J, Barrett A, Hombach J.
     Vaccine. 2011 Sep 23;29(42):7276-84.


555. Group B streptococcal vaccine for resource-poor countries
     Schrag SJ.
     Lancet. 2011 Mar 4.


556. Human vaccines and their importance to public health
     Schuchat A.
     Procedia Vaccinol. 2011 ;5(1):120-126.


557. The state of immunization 2013: we are the world
     Schuchat A.
     S D Med. 2013 ;Spec no:27-32.


558. Prioritization of pandemic influenza vaccine: rationale and strategy for decision making
     Schwartz B, Orenstein WA.
     Curr Top Microbiol Immunol. 2009 ;333:495-507.


559. Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities
     Scott JR, Millar EV, Lipsitch M, Moulton LH, Weatherholtz R, Perilla MJ, Jackson DM, Beall B, Craig MJ, Reid R, Santosham M, O'Brien KL.
     J Infect Dis. 2012 Jan;205(2):280-8.


560. Vaccines and neurologic disease
     Sejvar JJ.
     Semin Neurol. 2011 Jul;31(3):338-55.


561. Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data
     Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen D, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M.
     Vaccine. 2010 Jun 17.


562. Guillain-Barre syndrome following influenza vaccination: causal or coincidental?
     Sejvar JJ, Pfeifer D, Schonberger LB.
     Curr Infect Dis Rep. 2011 Jun 17.


563. Measles elimination in the Americas: a comparison between countries with a one-dose and two-dose routine vaccination schedule
     Sever AE, Rainey JJ, Zell ER, Hennessey K, Uzicanin A, Castillo-Solorzano C, Dietz V.
     J Infect Dis. 2011 Sep;204 Suppl 2:S748-55.


564. A rare event: a measles outbreak in a highly vaccinated two-dose population
     Seward JF, Orenstein WA.
     Clin Infect Dis. 2012 Apr 27.


565. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up
     Sharapov UM, Bulkow LR, Negus SE, Spradling PR, Homan C, Drobeniuc J, Bruce M, Kamili S, Hu DJ, McMahon BJ.
     Hepatology. 2012 Feb 28.


566. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up
     Sharapov UM, Bulkow LR, Negus SE, Spradling PR, Homan C, Drobeniuc J, Bruce M, Kamili S, Hu DJ, McMahon BJ.
     Hepatology. 2012 ;56(2):516-522.


567. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the pre-7-valent conjugate vaccine era
     Sharma D, Baughman W, Holst A, Thomas S, Jackson D, Carvalho MD, Beall B, Satola S, Jerris R, Jain S, Farley MM, Nuorti JP.
     Pediatr Infect Dis J. 2012 Oct 17.


568. Updated recommendations of the Advisory Committee on Immunization Practices for healthcare personnel vaccination: a necessary foundation for the essential work that remains to build successful programs
     Shefer A, Strikas R, Bridges CB.
     Infect Control Hosp Epidemiol. 2012 Jan;33(1):71-4.


569. The first National Adult Immunization Summit 2012: implementing change through action
     Shen AK, Bridges CB, Tan L.
     Vaccine. 2013 Jan 2;31(2):279-84.


570. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants
     Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E.
     JAMA. 2012 Feb 8;307(6):598-604.


571. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants
     Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E.
     JAMA. 2012 Feb 8;307(6):598-604.


572. Reduction in hepatitis B virus seroprevalence among U.S.-born children of foreign-born Asian parents-Benefit of universal infant hepatitis B vaccination
     Shuler CM, Fiore AE, Neeman R, Bell BP, Kuhnert W, Watkins S, Kilgour K, Arnold KE.
     Vaccine. 2009 Aug 10.


573. Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial
     Simberkoff MS, Arbeit RD, Johnson GR, Oxman MN, Boardman KD, Williams HM, Levin MJ, et al.
     Ann Intern Med. 2010 May 4;152(9):545-54.


574. Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector
     Simon JK, Carter M, Pasetti MF, Sztein MB, Kotloff KL, Weniger BG, Campbell JD, Levine MM.
     Vaccine. 2011 Nov 28;29(51):9544-50.


575. The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska Native children: results of a clinical trial
     Singleton R, Wenger J, Klejka JA, Bulkow LR, Thompson A, Sarkozy D, Emini EA, Gruber WC, Scott DA.
     Pediatr Infect Dis J. 2012 Sep 20.


576. Early impact of the US Tdap vaccination program on pertussis trends
     Skoff TH, Cohn AC, Clark TA, Messonnier NE, Martin SW.
     Arch Pediatr Adolesc Med. 2012 Jan 2.


577. Comment on the contribution by Souayah et al., "Guillain-Barre syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009"
     Slade BA, Gee J, Broder KR, Vellozzi C.
     Vaccine. 2011 Jan 29;29(5):865-6.


578. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine
     Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J.
     JAMA. 2009 Aug 19;302(7):750-7.


579. Vaccination for typhoid fever in sub-Saharan Africa
     Slayton RB, Date KA, Mintz ED.
     Hum Vaccin Immunother. 2013 Apr 1;9(4).


580. Acceptability of school requirements for human papillomavirus vaccine
     Smith JS, Brewer NT, Chang Y, Liddon N, Guerry S, Pettigrew E, Markowitz LE, Gottlieb SL.
     Hum Vaccin. 2011 Sep 1;7(9).


581. Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine
     Smith KJ, Wateska AR, Nowalk MP, Raymund M, Nuorti JP, Zimmerman RK.
     JAMA. 2012 Feb 22;307(8):804-12.


582. On-time vaccine receipt in the first year does not adversely affect neuropsychological outcomes
     Smith MJ, Woods CR.
     Pediatrics. 2010 May 24.


583. Parental delay or refusal of vaccine doses, childhood vaccination coverage at 24 months of age, and the Health Belief Model
     Smith PJ, Humiston SG, Marcuse EK, Zhao Z, Dorell CG, Howes C, Hibbs B.
     Public Health Rep. 2011 Jul-Aug;126 Suppl 2:135-46.


584. The association between intentional delay of vaccine administration and timely childhood vaccination coverage
     Smith PJ, Humiston SG, Parnell T, Vannice KS, Salmon DA.
     Public Health Rep. 2010 Jul-Aug;125(4):534-41.


585. Vaccination coverage among U.S. children aged 19-35 months entitled by the Vaccines for Children program, 2009
     Smith PJ, Lindley MC, Rodewald LE.
     Public Health Rep. 2011 Jul-Aug;126 Suppl 2:109-23.


586. Highlights of historical events leading to national surveillance of vaccination coverage in the United States
     Smith PJ, Wood D, Darden PM.
     Public Health Rep. 2011 Jul-Aug;126 Suppl 2:3-12.


587. Design of future rabies biologics and antiviral drugs
     Smith TG, Wu X, Franka R, Rupprecht CE.
     Adv Virus Res. 2011 ;79:345-63.


588. Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles
     Song JM, Hossain J, Yoo DG, Lipatov AS, Davis CT, Quan FS, Chen LM, Hogan RJ, Donis RO, Compans RW, Kang SM.
     Virology. 2010 Sep 15;405(1):165-75.


589. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles
     Song JM, Kim YC, Barlow PG, Hossain MJ, Park KM, Donis RO, Prausnitz MR, Compans RW, Kang SM.
     Antiviral Res. 2010 Nov;88(2):244-7.


590. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B and T cell responses in mice
     Song JM, Kim YC, Lipatov AS, Pearton M, Davis CT, Yoo DG, Park KM, Chen LM, Quan FS, Birchall J, Donis RO, Prausnitz MR, Compans RW, Kang SM.
     Clin Vaccine Immunol. 2010 Jul 14.


591. Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans
     Sow SO, Okoko BJ, Diallo A, Viviani S, Borrow R, Carlone G, Tapia M, Akinsola AK, Arduin P, Findlow H, Elie C, Haidara FC, Adegbola RA, Diop D, Parulekar V, Chaumont J, Martellet L, Diallo F, Idoko OT, Tang Y, Plikaytis BD, Kulkarni PS, Marchetti E, LaForce FM, Preziosi MP.
     N Engl J Med. 2011 Jun 16;364(24):2293-304.


592. Serologic testing for protection against hepatitis B virus infection among students at a health sciences university in the United States
     Spradling PR, Williams RE, Xing J, Soyemi K, Towers J.
     Infect Control Hosp Epidemiol. 2012 Jul;33(7):732-6.


593. Immunity to hepatitis B virus infection two decades after implementation of universal infant hepatitis B vaccination: the association of detectable residual antibody and response to a single hepatitis B vaccine challenge dose
     Spradling PR, Xing J, Williams R, Masunu-Faleafaga Y, Dulski T, Mahamud A, Drobeniuc J, Teshale EH.
     Clin Vaccine Immunol. 2013 Feb 13.


594. Effectiveness of pentavalent rotavirus vaccine against severe disease
     Staat MA, Payne DC, Donauer S, Weinberg GA, Edwards KM, Szilagyi PG, Griffin MR, Hall CB, Curns AT, Gentsch JR, Salisbury S, Fairbrother G, Parashar UD.
     Pediatrics. 2011 Aug;128(2):e267-e275.


595. Medical exemptions to school immunization requirements in the United States--association of state policies with medical exemption rates (2004-2011)
     Stadlin S, Bednarczyk RA, Omer SB.
     J Infect Dis. 2012 Aug 29.


596. Workshop on intussusception in African countries - meeting report
     Steele AD, Patel M, Cunliffe NA, Bresee JS, Borgstein E, Parashar UD.
     Vaccine. 2012 Apr 27;30 Suppl 1:A185-9.


597. Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers
     SteelFisher GK, Blendon RJ, Bekheit MM, Mitchell EW, Williams J, Lubell K, Peugh J, DiSogra CA.
     Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S116-23.


598. Health-related quality of life in the CDC Human Anthrax Vaccine Adsorbed Clinical Trial
     Stewart B, Rose CE, Tokars JI, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker SD, Jacobson RM, Poland GA, McNeil MM.
     Vaccine. 2012 Jul 16.


599. Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial
     Stewart B, Rose CE, Tokars JI, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker SD, Jacobson RM, Poland GA, McNeil MM.
     Vaccine. 2012 Aug 31;30(40):5875-9.


600. Health-related quality of life in the anthrax vaccination program for workers in the laboratory response network
     Stewart B, Zhang Y, Rose Jr CE, Tokars JI, Martin SW, Franzke LH, McNeil MM.
     Vaccine. 2012 Jan 6.


601. Lack of interference by zoster vaccine with the immune response to yellow fever vaccine
     Stier DM, Weber IB, Staples JE.
     J Travel Med. 2012 Mar;19(2):122-3.


602. 7-valent pneumococcal conjugate vaccine and otitis media: effectiveness of a 2-dose versus 3-dose primary series
     Stoecker C, Hampton LM, Moore MR.
     Vaccine. 2012 Aug 17.


603. Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward
     Stokes W, McFarland R, Kulpa-Eddy J, Gatewood D, Levis R, Halder M, Pulle G, Kojima H, Casey W, Gaydamaka A, Miller T, Brown K, Lewis C, Chapsal JM, Bruckner L, Gairola S, Kamphuis E, Rupprecht CE, Wunderli P, McElhinney L, De Mattia F, Gamoh K, Hill R, Reed D, Doelling V, Johnson N, Allen D, Rinckel L, Jones B.
     Biologicals. 2012 Sep;40(5):369-81.


604. Adolescent vaccination - coverage levels in the United States: 2006-2009
     Stokley S, Cohn A, Dorell C, Hariri S, Yankey D, Messonnier N, Wortley PM.
     Pediatrics. 2011 Nov 14.


605. Adolescent vaccination - coverage levels in the United States: 2006-2009
     Stokley S, Cohn A, Dorell C, Hariri S, Yankey D, Messonnier N, Wortley PM.
     Pediatrics. 2011 Nov 14.


606. Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 National Immunization Survey-Teen
     Stokley S, Cohn A, Jain N, McCauley MM.
     Arch Pediatr Adolesc Med. 2011 Sep;165(9):813-8.


607. Increasing adolescent vaccination coverage: the challenges that remain
     Stokley S, Vogt T, Shefer A.
     Arch Pediatr Adolesc Med. 2011 Jun;165(6):568-70.


608. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated
     Sugerman DE, Barskey AE, Delea MG, Ortega-Sanchez IR, Bi D, Ralston KJ, Rota PA, Waters-Montijo K, Lebaron CW.
     Pediatrics. 2010 Mar 22.


609. Preplanned national measles vaccination campaign at the beginning of a measles outbreak--Sierra Leone, 2009-2010
     Sugerman DE, Fall A, Guigui MT, N'Dolie M, Balogun T, Wurie A, Goodson JL.
     J Infect Dis. 2011 Jul;204 Suppl 1:S260-9.


610. The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus
     Suguitan AL, Marino MP, Desai PD, Chen LM, Matsuoka Y, Donis RO, Jin H, Swayne DE, Kemble G, Subbarao K.
     Virology. 2009 Dec 20;395(2):280-8.


611. Effectiveness and net cost of reminder/recall for adolescent immunizations
     Suh CA, Saville A, Daley MF, Glazner JE, Barrow J, Stokley S, Dong F, Beaty B, Dickinson LM, Kempe A.
     Pediatrics. 2012 May 7.


612. Effectiveness and net cost of reminder/recall for adolescent immunizations
     Suh CA, Saville A, Daley MF, Glazner JE, Barrow J, Stokley S, Dong F, Beaty B, Dickinson LM, Kempe A.
     Pediatrics. 2012 May 7.


613. Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old
     Sundaram ME, Talbot HK, Zhu Y, Griffin MR, Spencer S, Shay DK, Coleman LA.
     Vaccine. 2013 Apr 12;31(16):2057-61.


614. No evidence of murine leukemia virus-related viruses in live attenuated human vaccines
     Switzer WM, Zheng H, Simmons G, Zhou Y, Tang S, Shankar A, Kapusinszky B, Delwart EL, Heneine W.
     PLoS One. 2011 ;6(12):e29223.


615. Unintentional transfer of vaccinia virus associated with smallpox vaccines: ACAM2000 (R) compared with Dryvax (R)
     Tack DM, Karem KL, Montgomery JR, Collins L, Bryant-Genevier MG, Tiernan R, Cano M, Lewis P, Engler RJ, Damon IK, Reynolds MG.
     Hum Vaccin Immunother. 2013 Apr 9;9(7).


616. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak
     Talbot EA, Brown KH, Kirkland KB, Baughman AL, Halperin SA, Broder KR.
     Vaccine. 2010 Sep 24.


617. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak
     Talbot EA, Brown KH, Kirkland KB, Baughman AL, Halperin SA, Broder KR.
     Vaccine. 2010 Nov 23;28(50):8001-7.


618. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults
     Talbot HK, Coleman LA, Crimin K, Zhu Y, Rock MT, Meece J, Shay DK, Belongia EA, Griffin MR.
     Vaccine. 2012 Jun 6;30(26):3937-43.


619. Advances in the development of vaccines against Neisseria meningitidis
     Tan LK, Carlone GM, Borrow R.
     N Engl J Med. 2010 Apr 22;362(16):1511-20.


620. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa
     Tapia MD, Armah G, Breiman RF, Dallas MJ, Lewis KD, Sow SO, Rivers SB, Levine MM, Laserson KF, Feikin DR, Victor JC, Ciarlet M, Neuzil KM, Steele AD.
     Vaccine. 2012 Apr 27;30 Suppl 1:A79-85.


621. Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt
     Tartof S, Cohn A, Tarbangdo F, Djingarey MH, Messonnier N, Clark TA, Kambou JL, Novak R, Diomande FV, Medah I, Jackson ML.
     PLoS One. 2013 ;8(5):e63605.


622. Waning immunity to pertussis following 5 doses of DTaP
     Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA, Skoff TH.
     Pediatrics. 2013 Mar 11.


623. Waning immunity to pertussis following 5 doses of DTaP
     Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA, Skoff TH.
     Pediatrics. 2013 Mar 11.


624. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis
     Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD.
     Lancet Infect Dis. 2011 Oct 24.


625. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data
     Tate JE, Cortese MM, Payne DC, Curns AT, Yen C, Esposito DH, Cortes JE, Lopman BA, Patel MM, Gentsch JR, Parashar UD.
     Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S56-60.


626. Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the National Immunization Program in the United States, 2000-2012
     Tate JE, Haynes A, Payne DC, Cortese MM, Lopman BA, Patel MM, Parashar UD.
     Pediatr Infect Dis J. 2013 Feb 19.


627. Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda
     Tate JE, Kisakye A, Mugyenyi P, Kizza D, Odiit A, Braka F.
     Vaccine. 2011 Jan 14.


628. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006
     Tate JE, Mutuc JD, Panozzo CA, Payne DC, Cortese MM, Cortes JE, Yen C, Esposito DH, Lopman BA, Patel MM, Parashar UD.
     Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S30-4.


629. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine
     Tate JE, Panozzo CA, Payne DC, Patel MM, Cortese MM, Fowlkes AL, Parashar UD.
     Pediatrics. 2009 Aug;124(2):465-71.


630. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality
     Tate JE, Patel MM, Cortese MM, Lopman BA, Gentsch JR, Fleming J, Steele AD, Parashar UD.
     Expert Rev Vaccines. 2012 Feb;11(2):211-20.


631. Research priorities regarding rotavirus vaccine and intussusception: a meeting summary
     Tate JE, Steele AD, Bines JE, Zuber PL, Parashar UD.
     Vaccine. 2012 Apr 27;30 Suppl 1:A179-84.


632. Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008
     Taylor LD, Hariri S, Sternberg M, Dunne EF, Markowitz LE.
     Prev Med. 2011 May 1;52(5):398-400.


633. Optimal vaccine stockpile design for an eradicated disease: application to polio
     Tebbens RJ, Pallansch MA, Alexander JP, Thompson KM.
     Vaccine. 2010 Jun 11;28(26):4312-27.


634. Meningococcal conjugate vaccines: optimizing global impact
     Terranella A, Cohn A, Clark T.
     Infect Drug Resist. 2011 ;4:161-9.


635. Mycobacterium bovis (Bacille Calmette-Guerin) bacteremia in immunocompetent neonates following vaccination
     Thamthitiwat S, Marin N, Baggett HC, Peruski LF, Kiatkulwiwat W, Panumatrasmee V, Varma JK, Nateniyom S, Akarasewi P, Maloney SA.
     Vaccine. 2011 Feb 17;29(9):1727-30.


636. Actinic varicella vaccine rash
     Theodoridou K, Papaevangelou V, Papadogeorgaki E, Quinlivan M, Theodoridou M, Kakourou T, Breuer J.
     Pediatr Infect Dis J. 2011 Jul 15.


637. Haemophilus influenzae type b carriage among young children in metropolitan Atlanta in the context of vaccine shortage and booster dose deferral
     Thomas JD, Jackson ML, Sharma D, Mair R, Bach MC, Castillo D, Ejigiri OG, Satola S, Cohn AC, Jerris R, Jain S, Farley MM, Mayer LW, Messonnier NE.
     Clin Vaccine Immunol. 2011 Oct 19.


638. Enabling implementation of the Global Vaccine Action Plan: developing investment cases to achieve targets for measles and rubella prevention
     Thompson KM, Strebel PM, Dabbagh A, Cherian T, Cochi SL.
     Vaccine. 2013 Apr 18;31 Suppl 2:B149-56.


639. Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities
     Tohme RA, Awosika-Olumo D, Nielsen C, Khuwaja S, Scott J, Xing J, Drobeniuc J, Hu DJ, Turner C, Wafeeg T, Sharapov U, Spradling PR.
     Vaccine. 2011 Oct 18.


640. Hepatitis B vaccination coverage and documented seroprotection among matriculating healthcare students at an academic institution in the United States
     Tohme RA, Ribner B, Huey MJ, Spradling PR.
     Infect Control Hosp Epidemiol. 2011 Aug;32(8):818-21.


641. The risk of Guillain-Barre syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses
     Tokars JI, Lewis P, Destefano F, Wise M, Viray M, Morgan O, Gargiullo P, Vellozzi C.
     Pharmacoepidemiol Drug Saf. 2012 Mar 8.


642. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains
     Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, Berman L, Breese Hall C, Monto AS, Griffin MR, Belongia E, Shay DK.
     Clin Infect Dis. 2012 Oct;55(7):951-959.


643. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011
     Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM.
     Vaccine. 2012 Mar 2;30(11):2024-2031.


644. Safety of zoster vaccine in adults from a large managed care cohort: a Vaccine Safety Datalink Study
     Tseng HF, Liu A, Sy L, Marcy SM, Fireman B, Weintraub E, Baggs J, Weinmann S, Baxter R, Nordin J, Daley MF, Jackson L, Jacobsen SJ.
     J Intern Med. 2011 Oct 25.


645. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men
     Tseng HF, Slezak JM, Quinn VP, Sy LS, Van den Eeden SK, Jacobsen SJ.
     JAMA. 2010 May 5;303(17):1699-706.


646. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population
     Tseng HF, Sy LS, Qian L, Marcy SM, Jackson LA, Glanz J, Nordin J, Baxter R, Naleway A, Donahue J, Weintraub E, Jacobsen SJ.
     Clin Infect Dis. 2013 Feb;56(3):315-321.


647. Risk perceptions, worry, or distrust: what drives pregnant women's decisions to accept the H1N1 vaccine?
     Tucker Edmonds BM, Coleman J, Armstrong K, Shea JA.
     Matern Child Health J. 2010 Oct 9.


648. Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal
     Upreti SR, Janusz K, Schluter WW, Bichha RP, Shakya G, Biggerstaff BJ, Shrestha MM, Sedai TR, Fischer M, Gibbons RV, Shrestha S, Hills SL.
     Am J Trop Med Hyg. 2013 Jan 28.


649. Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in Maine
     Uzicanin A, Thompson M, Smith P, Chaves SS, Foster L, Dube N, Graitcer S, Jackson R, Ferdinands J, Gargiullo P, Mills D, Monto AS, Shay DK.
     J Infect Dis. 2012 Oct;206(7):1059-1068.


650. Field effectiveness of live attenuated measles-containing vaccines: a review of published literature
     Uzicanin A, Zimmerman L.
     J Infect Dis. 2011 Jul;204 Suppl 1:S133-48.


651. Varicella-zoster virus subunit vaccine
     Vafai A.
     Open Vaccine Journal. 2009 ;2:17-27.


652. Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine
     van der Sanden S, Pallansch MA, van de Kassteele J, El-Sayed N, Sutter RW, Koopmans M, van der Avoort H.
     J Virol. 2009 Sep;83(17):8693-704.


653. Similar immunogenicity and safety of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine
     Van der Vliet D, Pepin S, Lambert M, Fauchoux N, Donazzolo Y, Dupuy M, Dakowski C, et al.
     Hum Vaccin. 2010 Oct 12;6(10).


654. A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination
     Van Effelterre T, Moore MR, Fierens F, Whitney CG, White L, Pelton SI, Hausdorff WP.
     Vaccine. 2010 May 7;28(21):3650-60.


655. Compared to subcutaneous tenofovir, oral tenofovir disoproxyl fumarate administration preferentially concentrates the drug into gut-associated lymphoid cells in simian immunodeficiency virus-infected macaques
     Van Rompay KK, Babusis D, Abbott Z, Geng Y, Jayashankar K, Johnson JA, Lipscomb J, Heneine W, Abel K, Ray AS.
     Antimicrob Agents Chemother. 2012 Sep;56(9):4980-4.


656. Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal
     Van Rompay KK, Trott KA, Jayashankar K, Geng Y, Labranche CC, Johnson JA, Landucci G, Lipscomb J, Tarara RP, Canfield DR, Heneine W, Forthal DN, Montefiori D, Abel K.
     Retrovirology. 2012 ;9:57.


657. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the vaccine adverse events reporting system, United States, October 1, 2009-January 31, 2010
     Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, Cano M, Lewis P, McNeil MM, Bryant M, Singleton J, Martin D, Destefano F.
     Vaccine. 2010 Sep 15.


658. Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness
     Vemula SV, Ahi YS, Swaim AM, Katz JM, Donis R, Sambhara S, Mittal SK.
     PLoS One. 2013 ;8(4):e62496.


659. RotaTeq((R)), a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe
     Vesikari T, Itzler R, Karvonen A, Korhonen T, Van Damme P, Behre U, Bona G, et al.
     Vaccine. 2009 Oct 29.


660. Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months
     Vesikari T, Karvonen A, Lindblad N, Korhonen T, Lommel P, Willems P, Dieussaert I, et al.
     Pediatr Infect Dis J. 2010 Jun;29(6):e47-56.


661. A norovirus vaccine on the horizon?
     Vinje J.
     J Infect Dis. 2010 Oct 27.


662. Factors associated with differential uptake of seasonal influenza immunizations among underserved communities during the 2009-2010 influenza season
     Vlahov D, Bond KT, Jones KC, Ompad DC.
     J Community Health. 2012 Apr;37(2):282-7.


663. Epilogue: School-located influenza vaccination during the 2009-2010 pandemic and beyond
     Vogt TM, Wortley PM.
     Pediatrics. 2012 Mar;129 Suppl 2:S107-9.


664. Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009
     von Gottberg A, Cohen C, Whitelaw A, Chhagan M, Flannery B, Cohen AL, de Gouveia L, Plessis MD, Madhi SA, Klugman KP.
     Vaccine. 2012 Jan 11;30(3):565-571.


665. The genetic match between vaccine strains and circulating seasonal influenza A viruses in Vietnam, 2001-2009
     Vuong CD, Hoang PM, Nguyen HL, Nguyen HT, Nguyen TC, Le TT, Dennis DT, Kapella BK, Kile JC, Le MQ.
     Influenza Other Respi Viruses. 2012 Nov 8.


666. Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in newborns in Africa
     Waggie Z, Geldenhuys H, Sutter RW, Jacks M, Mulenga H, Mahomed H, De Kock M, Hanekom W, Pallansch MA, Kahn AL, Burton AH, Sreevatsava M, Hussey G.
     J Infect Dis. 2012 Jan;205(2):228-36.


667. The feasibility of using mobile-phone based SMS reminders and conditional cash transfers to improve timely immunization in rural Kenya
     Wakadha H, Chandir S, Were EV, Rubin A, Obor D, Levine OS, Gibson DG, Odhiambo F, Laserson KF, Feikin DR.
     Vaccine. 2012 Dec 12.


668. Timing of hepatitis B vaccination and impact of non-simultaneous vaccination with DTP vaccine following introduction of a hepatitis B birth dose in the Philippines
     Wallace AS, Sobel H, Ryman TK, Mantaring Iii JB, Silvestre M, Thorley M, Ducusin J, Nyunt US.
     J Public Health Policy. 2012 Jun 7.


669. Influenza vaccination of household contacts of newborns: a hospital-based strategy to increase vaccination rates
     Walter EB, Allred NJ, Swamy GK, Hellkamp AS, Dolor RJ.
     Infect Control Hosp Epidemiol. 2010 Aug 30.


670. New vaccine introductions: assessing the impact and the opportunities for immunization and health systems strengthening
     Wang SA, Hyde TB, Mounier-Jack S, Brenzel L, Favin M, Gordon WS, Shearer JC, Mantel CF, Arora N, Durrheim D.
     Vaccine. 2013 Apr 18;31 Suppl 2:B122-8.


671. Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States
     Wang X, Cohn A, Comanducci M, Andrew L, Zhao X, Macneil JR, Schmink S, Muzzi A, Bambini S, Rappuoli R, Pizza M, Murphy E, Hoiseth SK, Jansen KU, Anderson AS, Harrison LH, Clark TA, Messonnier NE, Mayer LW.
     Vaccine. 2011 May 12.


672. Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets
     Wang Y, Azevedo M, Saif LJ, Gentsch JR, Glass RI, Jiang B.
     Vaccine. 2010 Jul 26;28(33):5432-6.


673. Evaluating the capability and cost of a mass influenza and pneumococcal vaccination clinic via computer simulation
     Washington ML.
     Med Decis Making. 2009 Jul;29(4):414-423.


674. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease
     Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, Santosham M, O'Brien KL.
     Clin Infect Dis. 2010 May 1;50(9):1238-46.


675. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination
     Wei CJ, Boyington JC, McTamney PM, Kong WP, Pearce MB, Xu L, Andersen H, Rao S, Tumpey TM, Yang ZY, Nabel GJ.
     Science. 2010 Aug 27;329(5995):1060-4.


676. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis
     Wei SC, Tatti K, Cushing K, Rosen J, Brown K, Cassiday P, Clark T, Olans R, Pawloski L, Martin M, Tondella ML, Martin SW.
     Clin Infect Dis. 2010 Jun 25.


677. Vaccine safety: current systems and recent findings
     Wharton M.
     Curr Opin Pediatr. 2009 Nov 27.


678. More evidence for use of pneumococcal conjugate vaccines
     Whitney CG.
     Lancet. 2012 Nov 15.


679. Viscerotropic disease following yellow fever vaccination in Peru
     Whittembury A, Ramirez G, Hernandez H, Ropero AM, Waterman S, Ticona M, Brinton M, Uchuya J, Gershman M, Toledo W, Staples E, Campos C, Martinez M, Chang GJ, Cabezas C, Lanciotti R, Zaki S, Montgomery JM, Monath T, Hayes E.
     Vaccine. 2009 Oct 9;27(43):5974-81.


680. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines
     Widdowson MA, Steele D, Vojdani J, Wecker J, Parashar U.
     J Infect Dis. 2009 Nov 1;200 Suppl 1:S1-8.


681. Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines
     Wiggan O, Livengood JA, Silengo SJ, Kinney RM, Osorio JE, Huang CY, Stinchcomb DT.
     Vaccine. 2011 Oct 6;29(43):7456-62.


682. Decline in gastroenteritis-related triage calls after rotavirus vaccine licensure
     Williams DJ, Edwards KM, Payne DC, Manning J, Parashar UD, Lopman BA.
     Pediatrics. 2012 Oct;130(4):e872-8.


683. Needlestick injury surveillance during mass vaccination clinics: lessons learned and why more is needed - Tri-County (Denver Metropolitan) region, Colorado, 2009
     Williams NJ, Ghosh TS, Vogt RL.
     Am J Infect Control. 2012 Feb 2.


684. Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak
     Williams RE, Sena AC, Moorman AC, Moore ZS, Sharapov UM, Drobenuic J, Hu DJ, Wood HW, Xing J, Spradling PR.
     Vaccine. 2012 Mar 12.


685. Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009
     Williams SE, Klein NP, Halsey N, Dekker CL, Baxter RP, Marchant CD, Larussa PS, Sparks RC, Tokars JI, Pahud BA, Aukes L, Jakob K, Coronel S, Choi H, Slade BA, Edwards KM.
     Vaccine. 2011 Sep 16;29(40):6920-7.


686. Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination
     Williams SE, Pahud BA, Vellozzi C, Donofrio PD, Dekker CL, Halsey N, Klein NP, Baxter RP, Marchant CD, Larussa PS, Barnett ED, Tokars JI, McGeeney BE, Sparks RC, Aukes LL, Jakob K, Coronel S, Sejvar JJ, Slade BA, Edwards KM.
     Vaccine. 2011 Oct 26;29(46):8302-8.


687. Factors associated with human papillomavirus vaccination among young adult women in the United States
     Williams WW, Lu PJ, Saraiya M, Yankey D, Dorell C, Rodriguez JL, Kepka D, Markowitz LE.
     Vaccine. 2013 Apr 30.


688. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans
     Wise ME, Viray M, Sejvar JJ, Lewis P, Baughman AL, Connor W, Danila R, Giambrone GP, Hale C, Hogan BC, Meek JI, Murphree R, Oh JY, Reingold A, Tellman N, Conner SM, Singleton JA, Lu PJ, Destefano F, Fridkin SK, Vellozzi C, Morgan OW.
     Am J Epidemiol. 2012 Jun 1;175(11):1110-9.


689. Invasive and in situ cervical cancer reported to the Vaccine Adverse Event Reporting System (VAERS)
     Wong C, Krashin J, Rue-Cover A, Saraiya M, Unger E, Calugar A, Markowitz L.
     J Womens Health (Larchmt). 2010 Feb 8.


690. Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008
     Wong CA, Berkowitz Z, Dorell CG, Price RA, Lee J, Saraiya M.
     Cancer. 2011 Jun 20.


691. Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries
     Wong CA, Saraiya M, Hariri S, Eckert L, Howlett RI, Markowitz LE, Brotherton JM, Sinka K, Martinez-Montanez OG, Kjaer SK, Dunne EF.
     Vaccine. 2010 Oct 21.


692. Ethnically diverse female university students' knowledge and attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer
     Wong LP, Sam IC.
     Eur J Obstet Gynecol Reprod Biol. 2009 Nov 10.


693. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine
     Woolpert T, Staples JE, Faix DJ, Nett RJ, Kosoy OI, Biggerstaff BJ, Johnson BW, Sracic M, Fischer M.
     Vaccine. 2012 Apr 26;30(20):3090-6.


694. Perceptions matter: beliefs about influenza vaccine and vaccination behavior among elderly white, black and Hispanic Americans
     Wooten KG, Wortley PM, Singleton JA, Euler GL.
     Vaccine. 2012 Aug 30.


695. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing
     Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, Ji W, Suo L, Liu D, Ma R, Yu R, Zhangzhu J, Liu W, Zeng Y, Li X, Zhang X, Pang X, Deng Y.
     N Engl J Med. 2010 Dec 16;363(25):2416-23.


696. From brain passage to cell adaptation: the road of human rabies vaccine development
     Wu X, Smith TG, Rupprecht CE.
     Expert Rev Vaccines. 2011 Nov;10(11):1597-608.


697. Varicella vaccine uptake in Shandong Province, China
     Xu A, Xu Q, Fang X, Bialek S, Wang C.
     Hum Vaccin Immunother. 2012 Sep 1;8(9).


698. Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China
     Yan D, Li L, Zhu S, Zhang Y, An J, Wang D, Wen N, Jorba J, Liu W, Zhong G, Huang L, Kew O, Liang X, Xu W.
     J Clin Microbiol. 2010 Sep;48(9):3274-80.


699. Successful immunization of an allogeneic bone marrow transplant recipient with live, attenuated yellow fever vaccine
     Yax JA, Farnon EC, Cary Engleberg N.
     J Travel Med. 2009 Sep-Oct;16(5):365-7.


700. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers
     Yeh SH, Gurtman A, Hurley DC, Block SL, Schwartz RH, Patterson S, Jansen KU, et al.
     Pediatrics. 2010 Sep;126(3):e493-505.


701. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador
     Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, Nolasco JB, De Oliveira LH, Pastor D, Tate JE, Parashar UD, Patel M.
     Pediatr Infect Dis J. 2010 Nov 2.


702. Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico
     Yen C, Figueroa JR, Uribe ES, Carmen-Hernandez LD, Tate JE, Parashar UD, Patel MM, Richardson Lopez-Collado V.
     J Infect Dis. 2011 Sep;204(5):783-6.


703. Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine
     Yen C, Jakob K, Esona MD, Peckham X, Rausch J, Hull JJ, Whittier S, Gentsch JR, Larussa P.
     Vaccine. 2011 May 31;29(24):4151-5.


704. Rotavirus vaccines: update on global impact and future priorities
     Yen C, Tate JE, Patel MM, Cortese MM, Lopman B, Fleming J, Lewis K, Jiang B, Gentsch J, Steele D, Parashar UD.
     Hum Vaccin. 2011 Dec 1;7(12).


705. Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009
     Yen C, Tate JE, Steiner CA, Cortese MM, Patel MM, Parashar UD.
     J Infect Dis. 2012 Apr 26.


706. Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction
     Yen C, Tate JE, Wenk JD, Harris JM, Parashar UD.
     Pediatrics. 2011 Jan;127(1):e9-e15.


707. No risk of Guillain-Barre syndrome found after meningococcal conjugate vaccination in two large cohort studies
     Yih WK, Weintraub E, Kulldorff M.
     Pharmacoepidemiol Drug Saf. 2012 Dec;21(12):1359-60.


708. Influence of cytokine gene variations on immunization to childhood vaccines
     Yucesoy B, Johnson VJ, Fluharty K, Kashon ML, Slaven JE, Wilson NW, Weissman DN, Biagini RE, Germolec DR, Luster MI.
     Vaccine. 2009 Nov 23;27(50):6991-7.


709. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine
     Zeeshan M, Alam MT, Vinayak S, Bora H, Tyagi RK, Alam MS, Choudhary V, Mittra P, Lumb V, Bharti PK, Udhayakumar V, Singh N, Jain V, Singh PP, Sharma YD.
     PLoS One. 2012 ;7(8):e43430.


710. Characterization of the cellular immune response in hepatitis C virus infection
     Zhang X, Dou J, Germann MW.
     Med Res Rev. 2009 Nov;29(6):843-66.


711. Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in China: current immunization strategy effectively prevented its sustained transmission
     Zhang Y, Yan D, Zhu S, Wen N, Li L, Wang H, Liu J, Ye X, Ding Z, Wang D, Zhu H, Chen L, Hou X, An H, Liang X, Luo H, Kew O, Xu W.
     J Infect Dis. 2010 Nov 4.


712. Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007, USA
     Zhao Z, Murphy TV, Jacques-Carroll L.
     Vaccine. 2011 Nov 4.


713. Trends in vaccination coverage disparities among children, United States, 2001-2010
     Zhao Z, Smith PJ.
     Vaccine. 2012 May 15.


714. Trends in vaccination coverage disparities among children, United States, 2001-2010
     Zhao Z, Smith PJ.
     Vaccine. 2013 Mar 22.


715. Trends in early childhood vaccination coverage: progress towards US Healthy People 2010 goals
     Zhao Z, Smith PJ, Luman ET.
     Vaccine. 2009 Aug 6;27(36):5008-12.


716. Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System
     Zheteyeva Y, Moro P, Yue X, Broder K.
     Am J Obstet Gynecol. 2013 Feb 20.


717. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women
     Zheteyeva YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, Kissin D, Lewis PW, Yue X, Haber P, Tokars JI, Vellozzi C, Broder KR.
     Am J Obstet Gynecol. 2012 Jul;207(1):59 e1-7.


718. Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein
     Zhong L, Haynes L, Struble EB, Tamin A, Virata-Theimer ML, Zhang P.
     Biochem Biophys Res Commun. 2009 Dec 18;390(3):1056-60.


719. NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets
     Zhou B, Li Y, Belser JA, Pearce MB, Schmolke M, Subba AX, Shi Z, Zaki SR, Blau DM, Garcia-Sastre A, Tumpey TM, Wentworth DE.
     Vaccine. 2010 Nov 23;28(50):8015-25.


720. Use of standing orders for adult influenza vaccination: a national survey of primary care physicians
     Zimmerman RK, Albert SM, Nowalk MP, Yonas MA, Ahmed F.
     Am J Prev Med. 2011 Feb;40(2):144-8.


721. Factorial design for improving influenza vaccination among employees of a large health system
     Zimmerman RK, Nowalk MP, Lin CJ, Raymund M, Fox DE, Harper JD, Tanis MD, Willis BC.
     Infect Control Hosp Epidemiol. 2009 Jul;30(7):691-7.


722. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study
     Zinman L, Thoma J, Kwong JC, Kopp A, Stukel TA, Juurlink DN.
     Muscle Nerve. 2009 Dec;40(6):947-51.